{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:58:34Z","timestamp":1794254314649,"version":"4.9.0"},"reference-count":319,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Chongqing Municipality","award":["CSTB2023NSCQMSX0348"],"award-info":[{"award-number":["CSTB2023NSCQMSX0348"]}]},{"name":"the Science and Technology Research Program of Chongqing Municipal Education Commission","award":["KJQN202300114"],"award-info":[{"award-number":["KJQN202300114"]}],"id":[{"id":"https:\/\/ror.org\/031nm5713","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Basic Science Center for Complex System of Panvascular Intervention","award":["T2288101"],"award-info":[{"award-number":["T2288101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammation resolution is now understood as an active and highly coordinated biological process rather than a passive decline in inflammatory signals. When this program fails, inflammation may become persistent and gradually shift to a chronic pathological state. Such unresolved inflammation is increasingly recognized as a core driver of cardiovascular disease, metabolic disorders, autoimmune pathologies, neurodegeneration, and tumor progression. Although conventional anti-inflammatory drugs can suppress inflammatory mediators, they do not restore immune balance or actively promote resolution, and long-term administration may disrupt host defense and tissue-repair processes. Pro-resolving lipid mediators (PRLMs), including resolvins, maresins, protectins, and lipoxins, represent a distinct class of bioactive metabolites derived from polyunsaturated fatty acids. Recent studies have demonstrated that PRLMs regulate inflammation through specialized pro-resolving programs, such as enhancing efferocytosis, modulating cytokine networks, guiding leukocyte trafficking, and promoting tissue regeneration via receptor-dependent signaling pathways. These findings highlight a conceptual shift in inflammation management from broadly inhibiting inflammation to restoring immune homeostasis. Despite encouraging progress, several challenges hinder clinical translation, including rapid metabolic inactivation, limited delivery strategies, and unresolved pharmacological parameters. In this review, we summarize the current advances in PRLM biosynthesis, signaling pathways, and biological functions across multiple disease contexts. We also discuss emerging therapeutic strategies, biomarker development, and knowledge gaps that require further investigation. PRLM research offers a promising framework for next-generation resolution-based therapeutic interventions.<\/jats:p>","DOI":"10.1186\/s43556-025-00400-5","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T03:54:19Z","timestamp":1767585259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication"],"prefix":"10.1186","volume":"7","author":[{"given":"Chaofu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4873-7514","authenticated-orcid":false,"given":"Chuanwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"6571","key":"400_CR1","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1126\/science.abi5200","volume":"374","author":"R Medzhitov","year":"2021","unstructured":"Medzhitov R. The spectrum of inflammatory responses. Science. 2021;374(6571):1070\u20135. https:\/\/doi.org\/10.1126\/science.abi5200.","journal-title":"Science"},{"issue":"1","key":"400_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/circresaha.111.243162","volume":"110","author":"NG Frangogiannis","year":"2012","unstructured":"Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110(1):159\u201373. https:\/\/doi.org\/10.1161\/circresaha.111.243162.","journal-title":"Circ Res"},{"key":"400_CR3","doi-asserted-by":"publisher","first-page":"103992","DOI":"10.1016\/j.ebiom.2022.103992","volume":"79","author":"GV Halade","year":"2022","unstructured":"Halade GV, Lee DH. Inflammation and resolution signaling in cardiac repair and heart failure. EBioMedicine. 2022;79:103992. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103992.","journal-title":"EBioMedicine"},{"issue":"11","key":"400_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41581-021-00454-y","volume":"17","author":"E Brennan","year":"2021","unstructured":"Brennan E, Kantharidis P, Cooper ME, Godson C. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function. Nat Rev Nephrol. 2021;17(11):725\u201339. https:\/\/doi.org\/10.1038\/s41581-021-00454-y.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"400_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12944-024-02207-9","volume":"23","author":"X Liu","year":"2024","unstructured":"Liu X, Tang Y, Luo Y, Gao Y, He L. Role and mechanism of specialized pro-resolving mediators in obesity-associated insulin resistance. Lipids Health Dis. 2024;23(1):234. https:\/\/doi.org\/10.1186\/s12944-024-02207-9.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"400_CR6","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1067\/mai.2002.124655","volume":"109","author":"C Traidl-Hoffmann","year":"2002","unstructured":"Traidl-Hoffmann C, Kasche A, Jakob T, Huger M, Pl\u00f6tz S, Feussner I, et al. Lipid mediators from pollen act as chemoattractants and activators of polymorphonuclear granulocytes. J Allergy Clin Immunol. 2002;109(5):831\u20138. https:\/\/doi.org\/10.1067\/mai.2002.124655.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"400_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1161\/circulationaha.120.044581","volume":"143","author":"E Forte","year":"2021","unstructured":"Forte E, Perkins B, Sintou A, Kalkat HS, Papanikolaou A, Jenkins C, et al. Cross-priming dendritic cells exacerbate immunopathology after ischemic tissue damage in the heart. Circulation. 2021;143(8):821\u201336. https:\/\/doi.org\/10.1161\/circulationaha.120.044581.","journal-title":"Circulation"},{"key":"400_CR8","doi-asserted-by":"publisher","first-page":"108484","DOI":"10.1016\/j.pharmthera.2023.108484","volume":"249","author":"AK Reinhold","year":"2023","unstructured":"Reinhold AK, Hartmannsberger B, Burek M, Rittner HL. Stabilizing the neural barrier - a novel approach in pain therapy. Pharmacol Ther. 2023;249:108484. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108484.","journal-title":"Pharmacol Ther"},{"key":"400_CR9","doi-asserted-by":"publisher","first-page":"768133","DOI":"10.3389\/fimmu.2021.768133","volume":"12","author":"J Perez-Hernandez","year":"2021","unstructured":"Perez-Hernandez J, Chiurchi\u00f9 V, Perruche S, You S. Regulation of T-cell immune responses by pro-resolving lipid mediators. Front Immunol. 2021;12:768133. https:\/\/doi.org\/10.3389\/fimmu.2021.768133.","journal-title":"Front Immunol"},{"issue":"7","key":"400_CR10","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1172\/jci97950","volume":"128","author":"C Kasikara","year":"2018","unstructured":"Kasikara C, Doran AC, Cai B, Tabas I. The role of non-resolving inflammation in atherosclerosis. J Clin Invest. 2018;128(7):2713\u201323. https:\/\/doi.org\/10.1172\/jci97950.","journal-title":"J Clin Invest"},{"key":"400_CR11","doi-asserted-by":"publisher","first-page":"1288722","DOI":"10.3389\/froh.2023.1288722","volume":"4","author":"V Sahni","year":"2023","unstructured":"Sahni V, Van Dyke TE. Immunomodulation of periodontitis with SPMs. Front Oral Health. 2023;4:1288722. https:\/\/doi.org\/10.3389\/froh.2023.1288722.","journal-title":"Front Oral Health"},{"issue":"3","key":"400_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/ebc20200018","volume":"64","author":"N Chiang","year":"2020","unstructured":"Chiang N, Serhan CN. Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem. 2020;64(3):443\u201362. https:\/\/doi.org\/10.1042\/ebc20200018.","journal-title":"Essays Biochem"},{"key":"400_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073592","author":"LS D\u00edaz Del Campo","year":"2022","unstructured":"D\u00edaz Del Campo LS, Rodrigues-D\u00edez R, Salaices M, Briones AM, Garc\u00eda-Redondo AB. Specialized pro-resolving lipid mediators: new therapeutic approaches for vascular remodeling. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23073592.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"400_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/0006-291x(84)91486-4","volume":"118","author":"CN Serhan","year":"1984","unstructured":"Serhan CN, Hamberg M, Samuelsson B. Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes. Biochem Biophys Res Commun. 1984;118(3):943\u20139. https:\/\/doi.org\/10.1016\/0006-291x(84)91486-4.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"400_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1021\/acsptsci.9b00075","volume":"3","author":"J Park","year":"2020","unstructured":"Park J, Langmead CJ, Riddy DM. New advances in targeting the resolution of inflammation: implications for specialized pro-resolving mediator GPCR drug discovery. ACS Pharmacol Transl Sci. 2020;3(1):88\u2013106. https:\/\/doi.org\/10.1021\/acsptsci.9b00075.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"5","key":"400_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1084\/jem.20042031","volume":"201","author":"M Arita","year":"2005","unstructured":"Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med. 2005;201(5):713\u201322. https:\/\/doi.org\/10.1084\/jem.20042031.","journal-title":"J Exp Med"},{"issue":"1","key":"400_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbrc.2005.07.181","volume":"338","author":"M Arita","year":"2005","unstructured":"Arita M, Clish CB, Serhan CN. The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochem Biophys Res Commun. 2005;338(1):149\u201357. https:\/\/doi.org\/10.1016\/j.bbrc.2005.07.181.","journal-title":"Biochem Biophys Res Commun"},{"key":"400_CR18","doi-asserted-by":"publisher","first-page":"101597","DOI":"10.1016\/j.smim.2022.101597","volume":"59","author":"CN Serhan","year":"2022","unstructured":"Serhan CN, Libreros S, Nshimiyimana R. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition. Semin Immunol. 2022;59:101597. https:\/\/doi.org\/10.1016\/j.smim.2022.101597.","journal-title":"Semin Immunol"},{"key":"400_CR19","doi-asserted-by":"publisher","first-page":"174527","DOI":"10.1016\/j.ejphar.2021.174527","volume":"911","author":"E Molaei","year":"2021","unstructured":"Molaei E, Molaei A, Hayes AW, Karimi G. Resolvin D1, therapeutic target in acute respiratory distress syndrome. Eur J Pharmacol. 2021;911:174527. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174527.","journal-title":"Eur J Pharmacol"},{"key":"400_CR20","doi-asserted-by":"publisher","first-page":"106634","DOI":"10.1016\/j.prostaglandins.2022.106634","volume":"160","author":"M Yang","year":"2022","unstructured":"Yang M, Song XQ, Han M, Liu H. The role of Resolvin D1 in liver diseases. Prostaglandins Other Lipid Mediat. 2022;160:106634. https:\/\/doi.org\/10.1016\/j.prostaglandins.2022.106634.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"400_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2017.08.002","volume":"64","author":"CN Serhan","year":"2018","unstructured":"Serhan CN, Chiang N, Dalli J. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol Aspects Med. 2018;64:1\u201317. https:\/\/doi.org\/10.1016\/j.mam.2017.08.002.","journal-title":"Mol Aspects Med"},{"issue":"7","key":"400_CR22","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1172\/jci97943","volume":"128","author":"CN Serhan","year":"2018","unstructured":"Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018;128(7):2657\u201369. https:\/\/doi.org\/10.1172\/jci97943.","journal-title":"J Clin Invest"},{"key":"400_CR23","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/srep01940","volume":"3","author":"J Dalli","year":"2013","unstructured":"Dalli J, Colas RA, Serhan CN. Novel n-3 immunoresolvents: structures and actions. Sci Rep. 2013;3:1940. https:\/\/doi.org\/10.1038\/srep01940.","journal-title":"Sci Rep"},{"issue":"1","key":"400_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jcmm.16098","volume":"25","author":"Y Wang","year":"2021","unstructured":"Wang Y, Leppert A, Tan S, van der Gaag B, Li N, Schultzberg M, et al. Maresin 1 attenuates pro-inflammatory activation induced by \u03b2-amyloid and stimulates its uptake. J Cell Mol Med. 2021;25(1):434\u201347. https:\/\/doi.org\/10.1111\/jcmm.16098.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"400_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20081880","volume":"206","author":"CN Serhan","year":"2009","unstructured":"Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med. 2009;206(1):15\u201323. https:\/\/doi.org\/10.1084\/jem.20081880.","journal-title":"J Exp Med"},{"issue":"7503","key":"400_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92\u2013101. https:\/\/doi.org\/10.1038\/nature13479.","journal-title":"Nature"},{"issue":"8","key":"400_CR27","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1161\/atvbaha.112.249508","volume":"32","author":"LV Norling","year":"2012","unstructured":"Norling LV, Dalli J, Flower RJ, Serhan CN, Perretti M. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol. 2012;32(8):1970\u20138. https:\/\/doi.org\/10.1161\/atvbaha.112.249508.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"400_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.chembiol.2012.11.010","volume":"20","author":"J Dalli","year":"2013","unstructured":"Dalli J, Winkler JW, Colas RA, Arnardottir H, Cheng CY, Chiang N, et al. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem Biol. 2013;20(2):188\u2013201. https:\/\/doi.org\/10.1016\/j.chembiol.2012.11.010.","journal-title":"Chem Biol"},{"issue":"7395","key":"400_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature11042","volume":"484","author":"N Chiang","year":"2012","unstructured":"Chiang N, Fredman G, B\u00e4ckhed F, Oh SF, Vickery T, Schmidt BA, et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature. 2012;484(7395):524\u20138. https:\/\/doi.org\/10.1038\/nature11042.","journal-title":"Nature"},{"issue":"1","key":"400_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2019.09.028","volume":"145","author":"BD Levy","year":"2020","unstructured":"Levy BD, Abdulnour RE, Tavares A, Br\u00fcggemann TR, Norris PC, Bai Y, et al. Cysteinyl maresins regulate the prophlogistic lung actions of cysteinyl leukotrienes. J Allergy Clin Immunol. 2020;145(1):335\u201344. https:\/\/doi.org\/10.1016\/j.jaci.2019.09.028.","journal-title":"J Allergy Clin Immunol"},{"key":"400_CR31","doi-asserted-by":"publisher","first-page":"175257","DOI":"10.1016\/j.ejphar.2022.175257","volume":"934","author":"J S\u00e4fholm","year":"2022","unstructured":"S\u00e4fholm J, Abma W, Bankova LG, Boyce JA, Al-Ameri M, Orre AC, et al. Cysteinyl-maresin 3 inhibits IL-13 induced airway hyperresponsiveness through alternative activation of the CysLT(1) receptor. Eur J Pharmacol. 2022;934:175257. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175257.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"400_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/bph.14336","volume":"176","author":"J Dalli","year":"2019","unstructured":"Dalli J, Serhan CN. Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology. Br J Pharmacol. 2019;176(8):1024\u201337. https:\/\/doi.org\/10.1111\/bph.14336.","journal-title":"Br J Pharmacol"},{"issue":"13","key":"400_CR33","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1016\/j.bmc.2019.05.018","volume":"27","author":"SH Burstein","year":"2019","unstructured":"Burstein SH. Eicosanoid mediation of cannabinoid actions. Bioorg Med Chem. 2019;27(13):2718\u201328. https:\/\/doi.org\/10.1016\/j.bmc.2019.05.018.","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"400_CR34","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1172\/jci124219","volume":"129","author":"YH Han","year":"2019","unstructured":"Han YH, Shin KO, Kim JY, Khadka DB, Kim HJ, Lee YM, et al. A maresin 1\/ROR\u03b1\/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis. J Clin Invest. 2019;129(4):1684\u201398. https:\/\/doi.org\/10.1172\/jci124219.","journal-title":"J Clin Invest"},{"issue":"3","key":"400_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1476-5381.2010.00909.x","volume":"161","author":"S Bang","year":"2010","unstructured":"Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW. Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol. 2010;161(3):707\u201320. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00909.x.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"400_CR36","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1172\/jci97951","volume":"128","author":"PF Duffney","year":"2018","unstructured":"Duffney PF, Falsetta ML, Rackow AR, Thatcher TH, Phipps RP, Sime PJ. Key roles for lipid mediators in the adaptive immune response. J Clin Invest. 2018;128(7):2724\u201331. https:\/\/doi.org\/10.1172\/jci97951.","journal-title":"J Clin Invest"},{"issue":"15","key":"400_CR37","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","volume":"120","author":"J Dalli","year":"2012","unstructured":"Dalli J, Serhan CN. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood. 2012;120(15):e60-72. https:\/\/doi.org\/10.1182\/blood-2012-04-423525.","journal-title":"Blood"},{"issue":"2","key":"400_CR38","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.4049\/jimmunol.1103483","volume":"189","author":"S Ramon","year":"2012","unstructured":"Ramon S, Gao F, Serhan CN, Phipps RP. Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. J Immunol. 2012;189(2):1036\u201342. https:\/\/doi.org\/10.4049\/jimmunol.1103483.","journal-title":"J Immunol"},{"key":"400_CR39","doi-asserted-by":"publisher","first-page":"101605","DOI":"10.1016\/j.smim.2022.101605","volume":"59","author":"WA Julliard","year":"2022","unstructured":"Julliard WA, Myo YPA, Perelas A, Jackson PD, Thatcher TH, Sime PJ. Specialized pro-resolving mediators as modulators of immune responses. Semin Immunol. 2022;59:101605. https:\/\/doi.org\/10.1016\/j.smim.2022.101605.","journal-title":"Semin Immunol"},{"issue":"10","key":"400_CR40","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1096\/fj.201800173R","volume":"32","author":"G Liu","year":"2018","unstructured":"Liu G, Gong Y, Zhang R, Piao L, Li X, Liu Q, et al. Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration. Faseb j. 2018;32(10):5413\u201325. https:\/\/doi.org\/10.1096\/fj.201800173R.","journal-title":"Faseb j"},{"issue":"1","key":"400_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jvs.2016.01.030","volume":"65","author":"B Wu","year":"2017","unstructured":"Wu B, Mottola G, Chatterjee A, Lance KD, Chen M, Siguenza IO, et al. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury. J Vasc Surg. 2017;65(1):207-17.e3. https:\/\/doi.org\/10.1016\/j.jvs.2016.01.030.","journal-title":"J Vasc Surg"},{"issue":"9","key":"400_CR42","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1172\/jci97947","volume":"128","author":"MS Conte","year":"2018","unstructured":"Conte MS, Desai TA, Wu B, Schaller M, Werlin E. Pro-resolving lipid mediators in vascular disease. J Clin Invest. 2018;128(9):3727\u201335. https:\/\/doi.org\/10.1172\/jci97947.","journal-title":"J Clin Invest"},{"issue":"6974","key":"400_CR43","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/427504a","volume":"427","author":"JX Kang","year":"2004","unstructured":"Kang JX, Wang J, Wu L, Kang ZB. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature. 2004;427(6974):504. https:\/\/doi.org\/10.1038\/427504a.","journal-title":"Nature"},{"issue":"19","key":"400_CR44","doi-asserted-by":"publisher","first-page":"11903","DOI":"10.3390\/ijms231911903","volume":"23","author":"L Hao","year":"2022","unstructured":"Hao L, Nie YH, Chen CY, Li XY, Kaliannan K, Kang JX. Omega-3 polyunsaturated fatty acids protect against high-fat diet-induced morphological and functional impairments of brown fat in transgenic fat-1 mice. Int J Mol Sci. 2022;23(19):11903. https:\/\/doi.org\/10.3390\/ijms231911903.","journal-title":"Int J Mol Sci."},{"key":"400_CR45","doi-asserted-by":"publisher","first-page":"838782","DOI":"10.3389\/fphar.2022.838782","volume":"13","author":"NH Schebb","year":"2022","unstructured":"Schebb NH, K\u00fchn H, Kahnt AS, Rund KM, O\u2019Donnell VB, Flamand N, et al. Formation, signaling and occurrence of specialized pro-resolving lipid mediators-what is the evidence so far? Front Pharmacol. 2022;13:838782. https:\/\/doi.org\/10.3389\/fphar.2022.838782.","journal-title":"Front Pharmacol"},{"key":"400_CR46","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.plipres.2023.101238","volume":"91","author":"G Musso","year":"2023","unstructured":"Musso G, Saba F, Cassader M, Gambino R. Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): recent advances. Prog Lipid Res. 2023;91:101238. https:\/\/doi.org\/10.1016\/j.plipres.2023.101238.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"400_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13075-020-2133-2","volume":"22","author":"W Sun","year":"2020","unstructured":"Sun W, Ma J, Zhao H, Xiao C, Zhong H, Ling H, et al. Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis. Arthritis Res Ther. 2020;22(1):61. https:\/\/doi.org\/10.1186\/s13075-020-2133-2.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"400_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41419-021-03562-6","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Sun S, Ling H, Ma J, Zhang X, Xie Z, et al. Protectin DX restores Treg\/T(h)17 cell balance in rheumatoid arthritis by inhibiting NLRP3 inflammasome via miR-20a. Cell Death Dis. 2021;12(3):280. https:\/\/doi.org\/10.1038\/s41419-021-03562-6.","journal-title":"Cell Death Dis"},{"issue":"1","key":"400_CR49","doi-asserted-by":"publisher","first-page":"28698","DOI":"10.1038\/s41598-024-80051-8","volume":"14","author":"FHM Chaim","year":"2024","unstructured":"Chaim FHM, Pascoal LB, de Castro MM, Palma BB, Rodrigues BL, Fagundes JJ, et al. The resolvin D2 and omega-3 polyunsaturated fatty acid as a new possible therapeutic approach for inflammatory bowel diseases. Sci Rep. 2024;14(1):28698. https:\/\/doi.org\/10.1038\/s41598-024-80051-8.","journal-title":"Sci Rep"},{"key":"400_CR50","doi-asserted-by":"publisher","unstructured":"Correction for Gobbetti et al., Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection. Proc Natl Acad Sci U S A. 2024;121(9):e2322427121. https:\/\/doi.org\/10.1073\/pnas.2322427121.","DOI":"10.1073\/pnas.2322427121"},{"issue":"9","key":"400_CR51","doi-asserted-by":"publisher","first-page":"109201","DOI":"10.1016\/j.celrep.2021.109201","volume":"35","author":"C Derada Troletti","year":"2021","unstructured":"Derada Troletti C, Enzmann G, Chiurchi\u00f9 V, Kamermans A, Tietz SM, Norris PC, et al. Pro-resolving lipid mediator lipoxin A(4) attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome. Cell Rep. 2021;35(9):109201. https:\/\/doi.org\/10.1016\/j.celrep.2021.109201.","journal-title":"Cell Rep"},{"issue":"8","key":"400_CR52","first-page":"1850","volume":"21","author":"Y Shi","year":"2017","unstructured":"Shi Y, Pan H, Zhang HZ, Zhao XY, Jin J, Wang HY. Lipoxin A4 mitigates experimental autoimmune myocarditis by regulating inflammatory response, NF-\u03baB and PI3K\/Akt signaling pathway in mice. Eur Rev Med Pharmacol Sci. 2017;21(8):1850\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"400_CR53","doi-asserted-by":"publisher","first-page":"166525","DOI":"10.1016\/j.bbadis.2022.166525","volume":"1868","author":"JA Espitia-Corredor","year":"2022","unstructured":"Espitia-Corredor JA, Shamoon L, Olivares-Silva F, Rimassa-Tar\u00e9 C, Mu\u00f1oz-Rodr\u00edguez C, Espinoza-P\u00e9rez C, et al. Resolvin E1 attenuates doxorubicin-induced cardiac fibroblast senescence: A key role for IL-1\u03b2. Biochim Biophys Acta Mol Basis Dis. 2022;1868(11):166525. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166525.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"400_CR54","doi-asserted-by":"publisher","first-page":"e0009978","DOI":"10.1371\/journal.pntd.0009978","volume":"15","author":"I Carrillo","year":"2021","unstructured":"Carrillo I, Rabelo RAN, Barbosa C, Rates M, Fuentes-Retamal S, Gonz\u00e1lez-Herrera F, et al. Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease. PLoS Negl Trop Dis. 2021;15(11):e0009978. https:\/\/doi.org\/10.1371\/journal.pntd.0009978.","journal-title":"PLoS Negl Trop Dis"},{"key":"400_CR55","doi-asserted-by":"publisher","first-page":"110657","DOI":"10.1016\/j.cellsig.2023.110657","volume":"106","author":"F Gonz\u00e1lez-Herrera","year":"2023","unstructured":"Gonz\u00e1lez-Herrera F, Anfossi R, Catal\u00e1n M, Guti\u00e9rrez-Figueroa R, Maya JD, D\u00edaz-Araya G, et al. Lipoxin A4 prevents high glucose-induced inflammatory response in cardiac fibroblast through FOXO1 inhibition. Cell Signal. 2023;106:110657. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110657.","journal-title":"Cell Signal"},{"issue":"1","key":"400_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11033-020-06133-8","volume":"48","author":"A Salas-Hern\u00e1ndez","year":"2021","unstructured":"Salas-Hern\u00e1ndez A, Espinoza-P\u00e9rez C, Vivar R, Espitia-Corredor J, Lillo J, Parra-Flores P, et al. Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro. Mol Biol Rep. 2021;48(1):57\u201366. https:\/\/doi.org\/10.1007\/s11033-020-06133-8.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"400_CR57","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1194\/jlr.P055418","volume":"56","author":"X Wang","year":"2015","unstructured":"Wang X, Hjorth E, Vedin I, Eriksdotter M, Freund-Levi Y, Wahlund LO, et al. Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study. J Lipid Res. 2015;56(3):674\u201381. https:\/\/doi.org\/10.1194\/jlr.P055418.","journal-title":"J Lipid Res"},{"issue":"4","key":"400_CR58","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1007\/s12035-015-9544-0","volume":"53","author":"M Zhu","year":"2016","unstructured":"Zhu M, Wang X, Hjorth E, Colas RA, Schroeder L, Granholm AC, et al. Pro-resolving lipid mediators improve neuronal survival and increase A\u03b242 phagocytosis. Mol Neurobiol. 2016;53(4):2733\u201349. https:\/\/doi.org\/10.1007\/s12035-015-9544-0.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"400_CR59","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1038\/s41467-019-11928-w","volume":"10","author":"P Krashia","year":"2019","unstructured":"Krashia P, Cordella A, Nobili A, La Barbera L, Federici M, Leuti A, et al. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson\u2019s disease. Nat Commun. 2019;10(1):3945. https:\/\/doi.org\/10.1038\/s41467-019-11928-w.","journal-title":"Nat Commun"},{"issue":"5","key":"400_CR60","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1096\/fj.201600859R","volume":"31","author":"L Mart\u00ednez-Fern\u00e1ndez","year":"2017","unstructured":"Mart\u00ednez-Fern\u00e1ndez L, Gonz\u00e1lez-Muniesa P, Laiglesia LM, S\u00e1inz N, Prieto-Hontoria PL, Escot\u00e9 X, et al. Maresin 1 improves insulin sensitivity and attenuates adipose tissue inflammation in ob\/ob and diet-induced obese mice. FASEB J. 2017;31(5):2135\u201345. https:\/\/doi.org\/10.1096\/fj.201600859R.","journal-title":"FASEB J"},{"key":"400_CR61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fendo.2020.00073","volume":"11","author":"S Dieckmann","year":"2020","unstructured":"Dieckmann S, Maurer S, Fromme T, Colson C, Virtanen KA, Amri EZ, et al. Fatty acid metabolite profiling reveals oxylipins as markers of brown but not brite adipose tissue. Front Endocrinol (Lausanne). 2020;11:73. https:\/\/doi.org\/10.3389\/fendo.2020.00073.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"400_CR62","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.4049\/jimmunol.1201272","volume":"189","author":"J Cl\u00e0ria","year":"2012","unstructured":"Cl\u00e0ria J, Dalli J, Yacoubian S, Gao F, Serhan CN. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol. 2012;189(5):2597\u2013605. https:\/\/doi.org\/10.4049\/jimmunol.1201272.","journal-title":"J Immunol"},{"issue":"6","key":"400_CR63","doi-asserted-by":"publisher","first-page":"e21592","DOI":"10.1096\/fj.202002531R","volume":"35","author":"E F\u00e9lix-Soriano","year":"2021","unstructured":"F\u00e9lix-Soriano E, S\u00e1inz N, Gil-Iturbe E, Collantes M, Fern\u00e1ndez-Galilea M, Castilla-Madrigal R, et al. Changes in brown adipose tissue lipid mediator signatures with aging, obesity, and DHA supplementation in female mice. FASEB J. 2021;35(6):e21592. https:\/\/doi.org\/10.1096\/fj.202002531R.","journal-title":"FASEB J"},{"issue":"1","key":"400_CR64","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12974-016-0777-2","volume":"14","author":"LB Pascoal","year":"2017","unstructured":"Pascoal LB, Bombassaro B, Ramalho AF, Coope A, Moura RF, Correa-da-Silva F, et al. Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity. J Neuroinflammation. 2017;14(1):5. https:\/\/doi.org\/10.1186\/s12974-016-0777-2.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"400_CR65","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.2337\/db12-0828","volume":"62","author":"A Neuhofer","year":"2013","unstructured":"Neuhofer A, Zeyda M, Mascher D, Itariu BK, Murano I, Leitner L, et al. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes. 2013;62(6):1945\u201356. https:\/\/doi.org\/10.2337\/db12-0828.","journal-title":"Diabetes"},{"key":"400_CR66","doi-asserted-by":"publisher","first-page":"108586","DOI":"10.1016\/j.intimp.2022.108586","volume":"107","author":"G Jia","year":"2022","unstructured":"Jia G, Wang X, Wu W, Zhang Y, Chen S, Zhao J, et al. LXA4 enhances prostate cancer progression by facilitating M2 macrophage polarization via inhibition of METTL3. Int Immunopharmacol. 2022;107:108586. https:\/\/doi.org\/10.1016\/j.intimp.2022.108586.","journal-title":"Int Immunopharmacol"},{"key":"400_CR67","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/1742-2094-9-278","volume":"9","author":"S Hu","year":"2012","unstructured":"Hu S, Mao-Ying QL, Wang J, Wang ZF, Mi WL, Wang XW, et al. Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines. J Neuroinflammation. 2012;9:278. https:\/\/doi.org\/10.1186\/1742-2094-9-278.","journal-title":"J Neuroinflammation"},{"key":"400_CR68","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.canlet.2018.01.072","volume":"420","author":"J Schnittert","year":"2018","unstructured":"Schnittert J, Heinrich MA, Kuninty PR, Storm G, Prakash J. Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer. Cancer Lett. 2018;420:247\u201358. https:\/\/doi.org\/10.1016\/j.canlet.2018.01.072.","journal-title":"Cancer Lett"},{"issue":"8","key":"400_CR69","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41419-020-02846-7","volume":"11","author":"H Kim","year":"2020","unstructured":"Kim H, Park SH, Han SY, Lee YS, Cho J, Kim JM. LXA(4)-FPR2 signaling regulates radiation-induced pulmonary fibrosis via crosstalk with TGF-\u03b2\/Smad signaling. Cell Death Dis. 2020;11(8):653. https:\/\/doi.org\/10.1038\/s41419-020-02846-7.","journal-title":"Cell Death Dis"},{"issue":"3","key":"400_CR70","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/atvbaha.120.315758","volume":"41","author":"Z Hosseini","year":"2021","unstructured":"Hosseini Z, Marinello M, Decker C, Sansbury BE, Sadhu S, Gerlach BD, et al. Resolvin D1 enhances necroptotic cell clearance through promoting macrophage fatty acid oxidation and oxidative phosphorylation. Arterioscler Thromb Vasc Biol. 2021;41(3):1062\u201375. https:\/\/doi.org\/10.1161\/atvbaha.120.315758.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"400_CR71","doi-asserted-by":"publisher","first-page":"12859","DOI":"10.1038\/ncomms12859","volume":"7","author":"G Fredman","year":"2016","unstructured":"Fredman G, Hellmann J, Proto JD, Kuriakose G, Colas RA, Dorweiler B, et al. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nat Commun. 2016;7:12859. https:\/\/doi.org\/10.1038\/ncomms12859.","journal-title":"Nat Commun"},{"issue":"9","key":"400_CR72","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1161\/circresaha.116.309492","volume":"119","author":"JR Viola","year":"2016","unstructured":"Viola JR, Lemnitzer P, Jansen Y, Csaba G, Winter C, Neideck C, et al. Resolving lipid mediators Maresin 1 and Resolvin D2 prevent atheroprogression in mice. Circ Res. 2016;119(9):1030\u20138. https:\/\/doi.org\/10.1161\/circresaha.116.309492.","journal-title":"Circ Res"},{"issue":"6","key":"400_CR73","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1096\/fj.14-265363","volume":"29","author":"D Akagi","year":"2015","unstructured":"Akagi D, Chen M, Toy R, Chatterjee A, Conte MS. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice. FASEB J. 2015;29(6):2504\u201313. https:\/\/doi.org\/10.1096\/fj.14-265363.","journal-title":"FASEB J"},{"issue":"3","key":"400_CR74","first-page":"1139","volume":"9","author":"H Zong","year":"2017","unstructured":"Zong H, Li X, Lin H, Hou C, Ma F. Lipoxin A4 pretreatment mitigates skeletal muscle ischemia-reperfusion injury in rats. Am J Transl Res. 2017;9(3):1139\u201350.","journal-title":"Am J Transl Res"},{"issue":"9","key":"400_CR75","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1161\/circulationaha.116.021894","volume":"134","author":"MJ Zhang","year":"2016","unstructured":"Zhang MJ, Sansbury BE, Hellmann J, Baker JF, Guo L, Parmer CM, et al. Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation. Circulation. 2016;134(9):666\u201380. https:\/\/doi.org\/10.1161\/circulationaha.116.021894.","journal-title":"Circulation"},{"key":"400_CR76","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jss.2018.07.049","volume":"233","author":"Y Makino","year":"2019","unstructured":"Makino Y, Miyahara T, Nitta J, Miyahara K, Seo A, Kimura M, et al. Proresolving lipid mediators resolvin D1 and protectin D1 isomer attenuate neointimal hyperplasia in the rat carotid artery balloon injury model. J Surg Res. 2019;233:104\u201310. https:\/\/doi.org\/10.1016\/j.jss.2018.07.049.","journal-title":"J Surg Res"},{"issue":"1","key":"400_CR77","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/hypertensionaha.122.19448","volume":"80","author":"LS D\u00edaz Del Campo","year":"2023","unstructured":"D\u00edaz Del Campo LS, Garc\u00eda-Redondo AB, Rodr\u00edguez C, Zaragoza C, Duro-S\u00e1nchez S, Palmas F, et al. Resolvin D2 attenuates cardiovascular damage in Angiotensin II-induced hypertension. Hypertension. 2023;80(1):84\u201396. https:\/\/doi.org\/10.1161\/hypertensionaha.122.19448.","journal-title":"Hypertension"},{"issue":"1","key":"400_CR78","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1038\/s41598-017-10441-8","volume":"7","author":"V Kain","year":"2017","unstructured":"Kain V, Liu F, Kozlovskaya V, Ingle KA, Bolisetty S, Agarwal A, et al. Resolution agonist 15-epi-lipoxin A(4) programs early activation of resolving phase in post-myocardial infarction healing. Sci Rep. 2017;7(1):9999. https:\/\/doi.org\/10.1038\/s41598-017-10441-8.","journal-title":"Sci Rep"},{"key":"400_CR79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2015.04.003","volume":"84","author":"V Kain","year":"2015","unstructured":"Kain V, Ingle KA, Colas RA, Dalli J, Prabhu SD, Serhan CN, et al. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. J Mol Cell Cardiol. 2015;84:24\u201335. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.04.003.","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"400_CR80","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/bph.14041","volume":"175","author":"G Liu","year":"2018","unstructured":"Liu G, Liu Q, Shen Y, Kong D, Gong Y, Tao B, et al. Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice. Br J Pharmacol. 2018;175(8):1205\u201316. https:\/\/doi.org\/10.1111\/bph.14041.","journal-title":"Br J Pharmacol"},{"issue":"Pt A","key":"400_CR81","doi-asserted-by":"publisher","first-page":"109369","DOI":"10.1016\/j.intimp.2022.109369","volume":"113","author":"F Wang","year":"2022","unstructured":"Wang F, Gong Y, Chen T, Li B, Zhang W, Yin L, et al. Maresin1 ameliorates ventricular remodelling and arrhythmia in mice models of myocardial infarction via NRF2\/HO-1 and TLR4\/NF-kB signalling. Int Immunopharmacol. 2022;113(Pt A):109369. https:\/\/doi.org\/10.1016\/j.intimp.2022.109369.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"400_CR82","doi-asserted-by":"publisher","first-page":"H153","DOI":"10.1152\/ajpheart.01057.2009","volume":"299","author":"KT Keyes","year":"2010","unstructured":"Keyes KT, Ye Y, Lin Y, Zhang C, Perez-Polo JR, Gjorstrup P, et al. Resolvin E1 protects the rat heart against reperfusion injury. Am J Physiol Heart Circ Physiol. 2010;299(1):H153\u201364. https:\/\/doi.org\/10.1152\/ajpheart.01057.2009.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"400_CR83","doi-asserted-by":"publisher","first-page":"H89","DOI":"10.1152\/ajpheart.00040.2017","volume":"313","author":"GV Halade","year":"2017","unstructured":"Halade GV, Kain V, Ingle KA, Prabhu SD. Interaction of 12\/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing. Am J Physiol Heart Circ Physiol. 2017;313(1):H89-h102. https:\/\/doi.org\/10.1152\/ajpheart.00040.2017.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"400_CR84","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.4049\/jimmunol.1101665","volume":"189","author":"AP Rogerio","year":"2012","unstructured":"Rogerio AP, Haworth O, Croze R, Oh SF, Uddin M, Carlo T, et al. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol. 2012;189(4):1983\u201391. https:\/\/doi.org\/10.4049\/jimmunol.1101665.","journal-title":"J Immunol"},{"issue":"2","key":"400_CR85","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bbrc.2008.01.012","volume":"367","author":"H Aoki","year":"2008","unstructured":"Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, et al. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun. 2008;367(2):509\u201315. https:\/\/doi.org\/10.1016\/j.bbrc.2008.01.012.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"400_CR86","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3945\/ajcn.112.041145","volume":"97","author":"J Li","year":"2013","unstructured":"Li J, Xun P, Zamora D, Sood A, Liu K, Daviglus M, et al. Intakes of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study. Am J Clin Nutr. 2013;97(1):173\u20138. https:\/\/doi.org\/10.3945\/ajcn.112.041145.","journal-title":"Am J Clin Nutr"},{"issue":"26","key":"400_CR87","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1056\/NEJMoa1503734","volume":"375","author":"H Bisgaard","year":"2016","unstructured":"Bisgaard H, Stokholm J, Chawes BL, Vissing NH, Bjarnad\u00f3ttir E, Schoos AM, et al. Fish oil-derived fatty acids in pregnancy and wheeze and asthma in offspring. N Engl J Med. 2016;375(26):2530\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1503734.","journal-title":"N Engl J Med"},{"key":"400_CR88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12944-016-0220-9","volume":"15","author":"N Scaglia","year":"2016","unstructured":"Scaglia N, Chatkin J, Chapman KR, Ferreira I, Wagner M, Selby P, et al. The relationship between omega-3 and smoking habit: a cross-sectional study. Lipids Health Dis. 2016;15:61. https:\/\/doi.org\/10.1186\/s12944-016-0220-9.","journal-title":"Lipids Health Dis"},{"key":"400_CR89","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1476-511x-12-117","volume":"12","author":"TP Novgorodtseva","year":"2013","unstructured":"Novgorodtseva TP, Denisenko YK, Zhukova NV, Antonyuk MV, Knyshova VV, Gvozdenko TA. Modification of the fatty acid composition of the erythrocyte membrane in patients with chronic respiratory diseases. Lipids Health Dis. 2013;12:117. https:\/\/doi.org\/10.1186\/1476-511x-12-117.","journal-title":"Lipids Health Dis"},{"issue":"8869","key":"400_CR90","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0140-6736(93)91594-c","volume":"342","author":"R Lawrence","year":"1993","unstructured":"Lawrence R, Sorrell ET. Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4. Lancet. 1993;342(8869):465\u20139. https:\/\/doi.org\/10.1016\/0140-6736(93)91594-c.","journal-title":"Lancet"},{"issue":"1","key":"400_CR91","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12967-021-02795-5","volume":"19","author":"S Doaei","year":"2021","unstructured":"Doaei S, Gholami S, Rastgoo S, Gholamalizadeh M, Bourbour F, Bagheri SE, et al. The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial. J Transl Med. 2021;19(1):128. https:\/\/doi.org\/10.1186\/s12967-021-02795-5.","journal-title":"J Transl Med"},{"key":"400_CR92","doi-asserted-by":"publisher","first-page":"120489","DOI":"10.1016\/j.lfs.2022.120489","volume":"299","author":"A Mazidimoradi","year":"2022","unstructured":"Mazidimoradi A, Alemzadeh E, Alemzadeh E, Salehiniya H. The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: a systematic review. Life Sci. 2022;299:120489. https:\/\/doi.org\/10.1016\/j.lfs.2022.120489.","journal-title":"Life Sci"},{"key":"400_CR93","doi-asserted-by":"publisher","first-page":"668760","DOI":"10.3389\/fimmu.2021.668760","volume":"12","author":"T Cheng","year":"2021","unstructured":"Cheng T, Ding S, Liu S, Li X, Tang X, Sun L. Resolvin D1 improves the Treg\/Th17 imbalance in systemic lupus erythematosus through miR-30e-5p. Front Immunol. 2021;12:668760. https:\/\/doi.org\/10.3389\/fimmu.2021.668760.","journal-title":"Front Immunol"},{"key":"400_CR94","doi-asserted-by":"publisher","first-page":"5264195","DOI":"10.1155\/2018\/5264195","volume":"2018","author":"L Navarini","year":"2018","unstructured":"Navarini L, Bisogno T, Margiotta DPE, Piccoli A, Angeletti S, Laudisio A, et al. Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results. J Immunol Res. 2018;2018:5264195. https:\/\/doi.org\/10.1155\/2018\/5264195.","journal-title":"J Immunol Res"},{"issue":"37","key":"400_CR95","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.1523\/jneurosci.0020-16.2016","volume":"36","author":"B Luo","year":"2016","unstructured":"Luo B, Han F, Xu K, Wang J, Liu Z, Shen Z, et al. Resolvin D1 programs inflammation resolution by increasing TGF-\u03b2 expression induced by dying cell clearance in experimental autoimmune neuritis. J Neurosci. 2016;36(37):9590\u2013603. https:\/\/doi.org\/10.1523\/jneurosci.0020-16.2016.","journal-title":"J Neurosci"},{"issue":"4","key":"400_CR96","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/01.asn.0000119962.69573.cc","volume":"15","author":"T Ohse","year":"2004","unstructured":"Ohse T, Ota T, Kieran N, Godson C, Yamada K, Tanaka T, et al. Modulation of interferon-induced genes by lipoxin analogue in anti-glomerular basement membrane nephritis. J Am Soc Nephrol. 2004;15(4):919\u201327. https:\/\/doi.org\/10.1097\/01.asn.0000119962.69573.cc.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"400_CR97","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1055\/a-1345-0173","volume":"129","author":"J Song","year":"2021","unstructured":"Song J, Sun R, Zhang Y, Fu Y, Zhao D. Role of the specialized pro-resolving mediator resolvin D1 in Hashimoto\u2019s thyroiditis. Exp Clin Endocrinol Diabetes. 2021;129(11):791\u20137. https:\/\/doi.org\/10.1055\/a-1345-0173.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"400_CR98","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.msard.2018.09.040","volume":"27","author":"X Wang","year":"2019","unstructured":"Wang X, Jiao W, Lin M, Lu C, Liu C, Wang Y, et al. Resolution of inflammation in neuromyelitis optica spectrum disorders. Mult Scler Relat Disord. 2019;27:34\u201341. https:\/\/doi.org\/10.1016\/j.msard.2018.09.040.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"400_CR99","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12933-025-02721-9","volume":"24","author":"P Qin","year":"2025","unstructured":"Qin P, Ho FK, Celis-Morales CA, Pell JP. Association between systemic inflammation biomarkers and incident cardiovascular disease in 423,701 individuals: evidence from the UK biobank cohort. Cardiovasc Diabetol. 2025;24(1):162. https:\/\/doi.org\/10.1186\/s12933-025-02721-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"400_CR100","doi-asserted-by":"publisher","first-page":"e70062","DOI":"10.1111\/apha.70062","volume":"241","author":"A De Bartolo","year":"2025","unstructured":"De Bartolo A, Romeo N, Angelone T, Rocca C. Specialized pro-resolving mediators as emerging players in cardioprotection: from inflammation resolution to therapeutic potential. Acta Physiol (Oxf). 2025;241(7):e70062. https:\/\/doi.org\/10.1111\/apha.70062.","journal-title":"Acta Physiol (Oxf)"},{"issue":"1","key":"400_CR101","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1536\/ihj.22-361","volume":"64","author":"C Sun","year":"2023","unstructured":"Sun C, Zheng W, Liang L, Zhang Z, Liu Z, Sun W, et al. Acute coronary syndrome may be associated with decreased resolvin D1-to-leukotriene B4 ratio. Int Heart J. 2023;64(1):22\u20137. https:\/\/doi.org\/10.1536\/ihj.22-361.","journal-title":"Int Heart J"},{"key":"400_CR102","doi-asserted-by":"publisher","first-page":"106618","DOI":"10.1016\/j.phrs.2022.106618","volume":"187","author":"R Chen","year":"2023","unstructured":"Chen R, Li J, Zhou J, Wang Y, Zhao X, Li N, et al. Prognostic impacts of Lipoxin A4 in patients with acute myocardial infarction: a prospective cohort study. Pharmacol Res. 2023;187:106618. https:\/\/doi.org\/10.1016\/j.phrs.2022.106618.","journal-title":"Pharmacol Res"},{"issue":"1","key":"400_CR103","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11845-024-03839-7","volume":"194","author":"G Wang","year":"2025","unstructured":"Wang G, Zhou L, Wang Z, Ali A, Wu L. Palmitoleic and oleic fatty acids as biomarkers for coronary heart disease: a predictive model. Ir J Med Sci. 2025;194(1):59\u201370. https:\/\/doi.org\/10.1007\/s11845-024-03839-7.","journal-title":"Ir J Med Sci"},{"key":"400_CR104","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ebiom.2019.07.024","volume":"46","author":"LE Fosshaug","year":"2019","unstructured":"Fosshaug LE, Colas RA, Anstensrud AK, Gregersen I, Nymo S, Sagen EL, et al. Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction. EBioMedicine. 2019;46:264\u201373. https:\/\/doi.org\/10.1016\/j.ebiom.2019.07.024.","journal-title":"EBioMedicine"},{"issue":"4","key":"400_CR105","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/cvr\/cvad175","volume":"120","author":"R Hiram","year":"2024","unstructured":"Hiram R, Xiong F, Naud P, Xiao J, Sosnowski DK, Le Quilliec E, et al. An inflammation resolution-promoting intervention prevents atrial fibrillation caused by left ventricular dysfunction. Cardiovasc Res. 2024;120(4):345\u201359. https:\/\/doi.org\/10.1093\/cvr\/cvad175.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"400_CR106","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10557-019-06884-y","volume":"33","author":"R Liu","year":"2019","unstructured":"Liu R, Li Z, Wang Q. Resolvin D1 attenuates myocardial infarction in a rodent model with the participation of the HMGB1 pathway. Cardiovasc Drugs Ther. 2019;33(4):399\u2013406. https:\/\/doi.org\/10.1007\/s10557-019-06884-y.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"7","key":"400_CR107","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1096\/fj.201701173RR","volume":"32","author":"GV Halade","year":"2018","unstructured":"Halade GV, Kain V, Serhan CN. Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure. FASEB J. 2018;32(7):3717\u201329. https:\/\/doi.org\/10.1096\/fj.201701173RR.","journal-title":"FASEB J"},{"key":"400_CR108","doi-asserted-by":"publisher","first-page":"231351","DOI":"10.1155\/2013\/231351","volume":"2013","author":"Q Zhao","year":"2013","unstructured":"Zhao Q, Shao L, Hu X, Wu G, Du J, Xia J, et al. Lipoxin A4 preconditioning and postconditioning protect myocardial ischemia\/reperfusion injury in rats. Mediators Inflamm. 2013;2013:231351. https:\/\/doi.org\/10.1155\/2013\/231351.","journal-title":"Mediators Inflamm"},{"key":"400_CR109","doi-asserted-by":"publisher","first-page":"108157","DOI":"10.1016\/j.pharmthera.2022.108157","volume":"235","author":"T Melnik","year":"2022","unstructured":"Melnik T, Jordan O, Corpataux JM, Delie F, Saucy F. Pharmacological prevention of intimal hyperplasia: a state-of-the-art review. Pharmacol Ther. 2022;235:108157. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108157.","journal-title":"Pharmacol Ther"},{"issue":"6s","key":"400_CR110","doi-asserted-by":"publisher","first-page":"A15","DOI":"10.1016\/j.jvs.2007.02.061","volume":"45 Suppl A","author":"A Muto","year":"2007","unstructured":"Muto A, Fitzgerald TN, Pimiento JM, Maloney SP, Teso D, Paszkowiak JJ, et al. Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons. J Vasc Surg. 2007;45 Suppl A(6s):A15-24. https:\/\/doi.org\/10.1016\/j.jvs.2007.02.061.","journal-title":"J Vasc Surg"},{"key":"400_CR111","doi-asserted-by":"publisher","first-page":"1497810","DOI":"10.3389\/fmed.2024.1497810","volume":"11","author":"M Taghavi","year":"2024","unstructured":"Taghavi M, Lengel\u00e9 A, Laureys M, Jacobs L, Kaysi S, Collart F, et al. Antiphospholipid antibodies positivity as a potential risk factor for restenosis following arteriovenous fistula stenting in hemodialysis patients: a pilot study. Front Med (Lausanne). 2024;11:1497810. https:\/\/doi.org\/10.3389\/fmed.2024.1497810.","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"400_CR112","doi-asserted-by":"publisher","first-page":"100679","DOI":"10.1016\/j.jlr.2024.100679","volume":"65","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zhao M, Xu Y, Zhang J, Peng S, Liu J, et al. Resolvin D2\/GPR 18 axis ameliorates pressure overload-induced heart failure by inhibiting pro-inflammatory macrophage polarization. J Lipid Res. 2024;65(12):100679. https:\/\/doi.org\/10.1016\/j.jlr.2024.100679.","journal-title":"J Lipid Res"},{"issue":"6","key":"400_CR113","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1096\/fj.12-225615","volume":"27","author":"T Miyahara","year":"2013","unstructured":"Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, Fitzgerald JM, et al. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J. 2013;27(6):2220\u201332. https:\/\/doi.org\/10.1096\/fj.12-225615.","journal-title":"FASEB J"},{"key":"400_CR114","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3389\/fphar.2018.01327","volume":"9","author":"G Artiach","year":"2018","unstructured":"Artiach G, Carracedo M, Cl\u00e0ria J, Laguna-Fernandez A, B\u00e4ck M. Opposing effects on vascular smooth muscle cell proliferation and macrophage-induced inflammation reveal a protective role for the proresolving lipid mediator receptor ChemR23 in intimal hyperplasia. Front Pharmacol. 2018;9:1327. https:\/\/doi.org\/10.3389\/fphar.2018.01327.","journal-title":"Front Pharmacol"},{"key":"400_CR115","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.actbio.2019.07.037","volume":"97","author":"J Shi","year":"2019","unstructured":"Shi J, Zhang X, Jiang L, Zhang L, Dong Y, Midgley AC, et al. Regulation of the inflammatory response by vascular grafts modified with Aspirin-Triggered Resolvin D1 promotes blood vessel regeneration. Acta Biomater. 2019;97:360\u201373. https:\/\/doi.org\/10.1016\/j.actbio.2019.07.037.","journal-title":"Acta Biomater"},{"key":"400_CR116","doi-asserted-by":"publisher","first-page":"106401","DOI":"10.1016\/j.prostaglandins.2019.106401","volume":"146","author":"G Mottola","year":"2020","unstructured":"Mottola G, Werlin EC, Wu B, Chen M, Chatterjee A, Schaller MS, et al. Oral resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model. Prostaglandins Other Lipid Mediat. 2020;146:106401. https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106401.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"400_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121581","author":"SP Kadatane","year":"2023","unstructured":"Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The role of inflammation in CKD. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12121581.","journal-title":"Cells"},{"issue":"4","key":"400_CR118","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41440-023-01195-0","volume":"46","author":"JP Xu","year":"2023","unstructured":"Xu JP, Zeng RX, Zhang YZ, Lin SS, Tan JW, Zhu HY, et al. Systemic inflammation markers and the prevalence of hypertension: a NHANES cross-sectional study. Hypertens Res. 2023;46(4):1009\u201319. https:\/\/doi.org\/10.1038\/s41440-023-01195-0.","journal-title":"Hypertens Res"},{"issue":"10","key":"400_CR119","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1161\/atvbaha.110.209908","volume":"30","author":"G Fredman","year":"2010","unstructured":"Fredman G, Van Dyke TE, Serhan CN. Resolvin E1 regulates adenosine diphosphate activation of human platelets. Arterioscler Thromb Vasc Biol. 2010;30(10):2005\u201313. https:\/\/doi.org\/10.1161\/atvbaha.110.209908.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"400_CR120","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41418-019-0370-1","volume":"27","author":"BD Gerlach","year":"2020","unstructured":"Gerlach BD, Marinello M, Heinz J, Rymut N, Sansbury BE, Riley CO, et al. Resolvin D1 promotes the targeting and clearance of necroptotic cells. Cell Death Differ. 2020;27(2):525\u201339. https:\/\/doi.org\/10.1038\/s41418-019-0370-1.","journal-title":"Cell Death Differ"},{"issue":"10","key":"400_CR121","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/ajh\/hpad062","volume":"36","author":"JM Edwards-Glenn","year":"2023","unstructured":"Edwards-Glenn JM, Fontes MT, Waigi EW, Costa TJ, Maiseyeu A, Webb RC, et al. Specialized pro-resolving mediator improves vascular relaxation via formyl peptide receptor-2. Am J Hypertens. 2023;36(10):542\u201350. https:\/\/doi.org\/10.1093\/ajh\/hpad062.","journal-title":"Am J Hypertens"},{"key":"400_CR122","doi-asserted-by":"publisher","first-page":"116564","DOI":"10.1016\/j.biopha.2024.116564","volume":"174","author":"R Rodrigues-Diez","year":"2024","unstructured":"Rodrigues-Diez R, Ballesteros-Martinez C, Moreno-Carriles RM, Nistal F, D\u00edaz Del Campo LS, Cachofeiro V, et al. Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors. Biomed Pharmacother. 2024;174:116564. https:\/\/doi.org\/10.1016\/j.biopha.2024.116564.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"400_CR123","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/molecules29102233","volume":"29","author":"L Byrne","year":"2024","unstructured":"Byrne L, Guiry PJ. Advances in the chemistry and biology of specialised pro-resolving mediators (SPMs). Molecules. 2024;29(10):2233. https:\/\/doi.org\/10.3390\/molecules29102233.","journal-title":"Molecules"},{"issue":"4","key":"400_CR124","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/circresaha.115.306256","volume":"118","author":"I Tabas","year":"2016","unstructured":"Tabas I, Bornfeldt KE. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016;118(4):653\u201367. https:\/\/doi.org\/10.1161\/circresaha.115.306256.","journal-title":"Circ Res"},{"issue":"8","key":"400_CR125","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1096\/fj.201500155R","volume":"30","author":"TK Elajami","year":"2016","unstructured":"Elajami TK, Colas RA, Dalli J, Chiang N, Serhan CN, Welty FK. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling. FASEB j. 2016;30(8):2792\u2013801. https:\/\/doi.org\/10.1096\/fj.201500155R.","journal-title":"FASEB j"},{"issue":"7","key":"400_CR126","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-019-0169-2","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M, Yurdagul A Jr, Tabas I, \u00d6\u00f6rni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389\u2013406. https:\/\/doi.org\/10.1038\/s41569-019-0169-2.","journal-title":"Nat Rev Cardiol"},{"issue":"22","key":"400_CR127","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1111\/bph.13707","volume":"174","author":"MH Petri","year":"2017","unstructured":"Petri MH, Laguna-Fernandez A, Arnardottir H, Wheelock CE, Perretti M, Hansson GK, et al. Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E(-\/-) mice. Br J Pharmacol. 2017;174(22):4043\u201354. https:\/\/doi.org\/10.1111\/bph.13707.","journal-title":"Br J Pharmacol"},{"issue":"16","key":"400_CR128","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/circulationaha.117.032801","volume":"138","author":"A Laguna-Fernandez","year":"2018","unstructured":"Laguna-Fernandez A, Checa A, Carracedo M, Artiach G, Petri MH, Baumgartner R, et al. ERV1\/ChemR23 signaling protects against atherosclerosis by modifying oxidized low-density lipoprotein uptake and phagocytosis in macrophages. Circulation. 2018;138(16):1693\u2013705. https:\/\/doi.org\/10.1161\/circulationaha.117.032801.","journal-title":"Circulation"},{"key":"400_CR129","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3389\/fphar.2018.01273","volume":"9","author":"J Pirault","year":"2018","unstructured":"Pirault J, B\u00e4ck M. Lipoxin and resolvin receptors transducing the resolution of inflammation in cardiovascular disease. Front Pharmacol. 2018;9:1273. https:\/\/doi.org\/10.3389\/fphar.2018.01273.","journal-title":"Front Pharmacol"},{"issue":"1","key":"400_CR130","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/cvr\/cvu224","volume":"105","author":"MH Petri","year":"2015","unstructured":"Petri MH, Laguna-Fern\u00e1ndez A, Gonzalez-Diez M, Paulsson-Berne G, Hansson GK, B\u00e4ck M. The role of the FPR2\/ALX receptor in atherosclerosis development and plaque stability. Cardiovasc Res. 2015;105(1):65\u201374. https:\/\/doi.org\/10.1093\/cvr\/cvu224.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"400_CR131","doi-asserted-by":"publisher","first-page":"e22173","DOI":"10.1096\/fj.202101219RR","volume":"36","author":"JD Kraft","year":"2022","unstructured":"Kraft JD, Blomgran R, Bergstr\u00f6m I, Sot\u00e1k M, Clark M, Rani A, et al. Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis. FASEB J. 2022;36(3):e22173. https:\/\/doi.org\/10.1096\/fj.202101219RR.","journal-title":"FASEB J"},{"issue":"1","key":"400_CR132","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41572-025-00617-2","volume":"11","author":"T Berger","year":"2025","unstructured":"Berger T, Dumfarth J, Kreibich M, Minatoya K, Ziganshin BA, Czerny M. Thoracic aortic aneurysm. Nat Rev Dis Primers. 2025;11(1):34. https:\/\/doi.org\/10.1038\/s41572-025-00617-2.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"400_CR133","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41590-025-02132-8","volume":"26","author":"D Thayaparan","year":"2025","unstructured":"Thayaparan D, Emoto T, Khan AB, Besla R, Hamidzada H, El-Maklizi M, et al. Endothelial dysfunction drives atherosclerotic plaque macrophage-dependent abdominal aortic aneurysm formation. Nat Immunol. 2025;26(5):706\u201321. https:\/\/doi.org\/10.1038\/s41590-025-02132-8.","journal-title":"Nat Immunol"},{"issue":"4","key":"400_CR134","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/circresaha.118.313187","volume":"124","author":"RA Quintana","year":"2019","unstructured":"Quintana RA, Taylor WR. Cellular mechanisms of aortic aneurysm formation. Circ Res. 2019;124(4):607\u201318. https:\/\/doi.org\/10.1161\/circresaha.118.313187.","journal-title":"Circ Res"},{"issue":"1","key":"400_CR135","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10753-011-9294-8","volume":"35","author":"PS Pillai","year":"2012","unstructured":"Pillai PS, Leeson S, Porter TF, Owens CD, Kim JM, Conte MS, et al. Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients. Inflammation. 2012;35(1):98\u2013113. https:\/\/doi.org\/10.1007\/s10753-011-9294-8.","journal-title":"Inflammation"},{"issue":"6","key":"400_CR136","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jacbts.2018.08.005","volume":"3","author":"MH Petri","year":"2018","unstructured":"Petri MH, Thul S, Andonova T, Lindquist-Liljeqvist M, Jin H, Skenteris NT, et al. Resolution of inflammation through the lipoxin and ALX\/FPR2 receptor pathway protects against abdominal aortic aneurysms. JACC Basic to Transl Sci. 2018;3(6):719\u201327. https:\/\/doi.org\/10.1016\/j.jacbts.2018.08.005.","journal-title":"JACC Basic to Transl Sci"},{"issue":"6s","key":"400_CR137","doi-asserted-by":"publisher","first-page":"93s","DOI":"10.1016\/j.jvs.2018.05.253","volume":"68","author":"M Spinosa","year":"2018","unstructured":"Spinosa M, Su G, Salmon MD, Lu G, Cullen JM, Fashandi AZ, et al. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model. J Vasc Surg. 2018;68(6s):93s\u2013103s. https:\/\/doi.org\/10.1016\/j.jvs.2018.05.253.","journal-title":"J Vasc Surg"},{"issue":"12","key":"400_CR138","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1096\/fj.201600144RR","volume":"30","author":"NH Pope","year":"2016","unstructured":"Pope NH, Salmon M, Davis JP, Chatterjee A, Su G, Conte MS, et al. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization. Faseb J. 2016;30(12):4192\u2013201. https:\/\/doi.org\/10.1096\/fj.201600144RR.","journal-title":"Faseb J"},{"issue":"12","key":"400_CR139","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822\u201332. https:\/\/doi.org\/10.1038\/s41591-019-0675-0.","journal-title":"Nat Med"},{"issue":"5","key":"400_CR140","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852\u201371. https:\/\/doi.org\/10.1016\/j.cell.2012.02.017.","journal-title":"Cell"},{"issue":"7","key":"400_CR141","doi-asserted-by":"publisher","first-page":"104602","DOI":"10.1016\/j.isci.2022.104602","volume":"25","author":"M Sot\u00e1k","year":"2022","unstructured":"Sot\u00e1k M, Rajan MR, Clark M, Harms M, Rani A, Kraft JD, et al. Lipoxins reduce obesity-induced adipose tissue inflammation in 3D-cultured human adipocytes and explant cultures. iScience. 2022;25(7):104602. https:\/\/doi.org\/10.1016\/j.isci.2022.104602.","journal-title":"iScience"},{"issue":"1","key":"400_CR142","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cmet.2015.05.003","volume":"22","author":"E B\u00f6rgeson","year":"2015","unstructured":"B\u00f6rgeson E, Johnson AM, Lee YS, Till A, Syed GH, Ali-Shah ST, et al. Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease. Cell Metab. 2015;22(1):125\u201337. https:\/\/doi.org\/10.1016\/j.cmet.2015.05.003.","journal-title":"Cell Metab"},{"issue":"4","key":"400_CR143","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.plipres.2006.02.003","volume":"45","author":"H K\u00fchn","year":"2006","unstructured":"K\u00fchn H, O\u2019Donnell VB. Inflammation and immune regulation by 12\/15-lipoxygenases. Prog Lipid Res. 2006;45(4):334\u201356. https:\/\/doi.org\/10.1016\/j.plipres.2006.02.003.","journal-title":"Prog Lipid Res"},{"key":"400_CR144","doi-asserted-by":"publisher","first-page":"106610","DOI":"10.1016\/j.prostaglandins.2021.106610","volume":"159","author":"AT \u00d6zdemir","year":"2022","unstructured":"\u00d6zdemir AT, Nalbantsoy A, \u00d6zg\u00fcl \u00d6zdemir RB, Berdeli A. Effects of 15-lipoxygenase overexpressing adipose tissue mesenchymal stem cells on the Th17 \/ Treg plasticity. Prostaglandins Other Lipid Mediat. 2022;159:106610. https:\/\/doi.org\/10.1016\/j.prostaglandins.2021.106610.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"40","key":"400_CR145","doi-asserted-by":"publisher","first-page":"14530","DOI":"10.1073\/pnas.1410851111","volume":"111","author":"G Fredman","year":"2014","unstructured":"Fredman G, Ozcan L, Spolitu S, Hellmann J, Spite M, Backs J, et al. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway. Proc Natl Acad Sci U S A. 2014;111(40):14530\u20135. https:\/\/doi.org\/10.1073\/pnas.1410851111.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"400_CR146","doi-asserted-by":"publisher","first-page":"103909","DOI":"10.1016\/j.ebiom.2022.103909","volume":"77","author":"HL Fisk","year":"2022","unstructured":"Fisk HL, Childs CE, Miles EA, Ayres R, Noakes PS, Paras-Chavez C, et al. Modification of subcutaneous white adipose tissue inflammation by omega-3 fatty acids is limited in human obesity-a double blind, randomised clinical trial. EBioMedicine. 2022;77:103909. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103909.","journal-title":"EBioMedicine"},{"key":"400_CR147","doi-asserted-by":"publisher","first-page":"112055","DOI":"10.1016\/j.nut.2023.112055","volume":"111","author":"N Bakker","year":"2023","unstructured":"Bakker N, Hickey M, Shams R, Rivera CF, Vlahos J, Cense HA, et al. Oral \u03c9-3 PUFA supplementation modulates inflammation in adipose tissue depots in morbidly obese women: a randomized trial. Nutrition. 2023;111:112055. https:\/\/doi.org\/10.1016\/j.nut.2023.112055.","journal-title":"Nutrition"},{"issue":"6","key":"400_CR148","doi-asserted-by":"publisher","first-page":"e22354","DOI":"10.1096\/fj.202200350R","volume":"36","author":"AE Al-Shaer","year":"2022","unstructured":"Al-Shaer AE, Pal A, Shi Q, Carson MS, Regan J, Behee M, et al. Modeling human heterogeneity of obesity with diversity outbred mice reveals a fat mass-dependent therapeutic window for resolvin E1. Faseb j. 2022;36(6):e22354. https:\/\/doi.org\/10.1096\/fj.202200350R.","journal-title":"Faseb j"},{"key":"400_CR149","doi-asserted-by":"publisher","first-page":"102363","DOI":"10.1016\/j.plefa.2021.102363","volume":"174","author":"C Gemperle","year":"2021","unstructured":"Gemperle C, Tran S, Schmid M, Rimann N, Marti-Jaun J, Hartling I, et al. Resolvin D1 reduces inflammation in co-cultures of primary human macrophages and adipocytes by triggering macrophages. Prostaglandins Leukot Essent Fatty Acids. 2021;174:102363. https:\/\/doi.org\/10.1016\/j.plefa.2021.102363.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"400_CR150","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s13105-020-00775-9","volume":"77","author":"L Mart\u00ednez-Fern\u00e1ndez","year":"2021","unstructured":"Mart\u00ednez-Fern\u00e1ndez L, Gonz\u00e1lez-Muniesa P, S\u00e1inz N, Escot\u00e9 X, Mart\u00ednez JA, Arbones-Mainar JM, et al. Maresin 1 regulates insulin signaling in human adipocytes as well as in adipose tissue and muscle of lean and obese mice. J Physiol Biochem. 2021;77(1):167\u201373. https:\/\/doi.org\/10.1007\/s13105-020-00775-9.","journal-title":"J Physiol Biochem"},{"issue":"6","key":"400_CR151","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s42255-022-00590-0","volume":"4","author":"S Sugimoto","year":"2022","unstructured":"Sugimoto S, Mena HA, Sansbury BE, Kobayashi S, Tsuji T, Wang CH, et al. Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation. Nat Metab. 2022;4(6):775\u201390. https:\/\/doi.org\/10.1038\/s42255-022-00590-0.","journal-title":"Nat Metab"},{"key":"400_CR152","doi-asserted-by":"publisher","first-page":"101749","DOI":"10.1016\/j.molmet.2023.101749","volume":"74","author":"LM Laiglesia","year":"2023","unstructured":"Laiglesia LM, Escot\u00e9 X, S\u00e1inz N, Felix-Soriano E, Santamar\u00eda E, Collantes M, et al. Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice. Mol Metab. 2023;74:101749. https:\/\/doi.org\/10.1016\/j.molmet.2023.101749.","journal-title":"Mol Metab"},{"issue":"4","key":"400_CR153","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson 3rd","year":"2023","unstructured":"Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693\u2013714. https:\/\/doi.org\/10.1016\/j.cell.2022.12.032.","journal-title":"Cell"},{"issue":"1","key":"400_CR154","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42. https:\/\/doi.org\/10.1186\/s40035-020-00221-2.","journal-title":"Transl Neurodegener"},{"issue":"7","key":"400_CR155","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.3390\/ijms24076518","volume":"24","author":"B Twarowski","year":"2023","unstructured":"Twarowski B, Herbet M. Inflammatory processes in alzheimer\u2019s disease-pathomechanism, diagnosis and treatment: a review. Int J Mol Sci. 2023;24(7):6518. https:\/\/doi.org\/10.3390\/ijms24076518.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"400_CR156","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jalz.2013.12.024","volume":"11","author":"X Wang","year":"2015","unstructured":"Wang X, Zhu M, Hjorth E, Cort\u00e9s-Toro V, Eyjolfsdottir H, Graff C, et al. Resolution of inflammation is altered in Alzheimer\u2019s disease. Alzheimers Dement. 2015;11(1):40-50. 50.e1-2. https:\/\/doi.org\/10.1016\/j.jalz.2013.12.024.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"400_CR157","doi-asserted-by":"publisher","first-page":"112617","DOI":"10.1016\/j.celrep.2023.112617","volume":"42","author":"L Li","year":"2023","unstructured":"Li L, Cheng SQ, Sun YQ, Yu JB, Huang XX, Dong YF, et al. Resolvin D1 reprograms energy metabolism to promote microglia to phagocytize neutrophils after ischemic stroke. Cell Rep. 2023;42(6):112617. https:\/\/doi.org\/10.1016\/j.celrep.2023.112617.","journal-title":"Cell Rep"},{"issue":"2","key":"400_CR158","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312\u201339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001.","journal-title":"Cell"},{"issue":"2","key":"400_CR159","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X. Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell. 2025;16(2):83\u2013120. https:\/\/doi.org\/10.1093\/procel\/pwae026.","journal-title":"Protein Cell"},{"issue":"15","key":"400_CR160","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.3390\/molecules27154836","volume":"27","author":"M Valente","year":"2022","unstructured":"Valente M, Dentoni M, Bellizzi F, Kuris F, Gigli GL. Specialized pro-resolving mediators in neuroinflammation: overview of studies and perspectives of clinical applications. Molecules. 2022;27(15):4836. https:\/\/doi.org\/10.3390\/molecules27154836.","journal-title":"Molecules"},{"issue":"2","key":"400_CR161","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10571-022-01216-5","volume":"43","author":"KV Do","year":"2023","unstructured":"Do KV, Hjorth E, Wang Y, Jun B, Kautzmann MI, Ohshima M, et al. Cerebrospinal fluid profile of lipid mediators in Alzheimer\u2019s disease. Cell Mol Neurobiol. 2023;43(2):797\u2013811. https:\/\/doi.org\/10.1007\/s10571-022-01216-5.","journal-title":"Cell Mol Neurobiol"},{"key":"400_CR162","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.expneurol.2017.11.005","volume":"300","author":"A Kantarci","year":"2018","unstructured":"Kantarci A, Aytan N, Palaska I, Stephens D, Crabtree L, Benincasa C, et al. Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer\u2019s disease. Exp Neurol. 2018;300:111\u201320. https:\/\/doi.org\/10.1016\/j.expneurol.2017.11.005.","journal-title":"Exp Neurol"},{"key":"400_CR163","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fphar.2020.00612","volume":"11","author":"C Li","year":"2020","unstructured":"Li C, Wu X, Liu S, Shen D, Zhu J, Liu K. Role of resolvins in the inflammatory resolution of neurological diseases. Front Pharmacol. 2020;11:612. https:\/\/doi.org\/10.3389\/fphar.2020.00612.","journal-title":"Front Pharmacol"},{"key":"400_CR164","doi-asserted-by":"publisher","first-page":"110109","DOI":"10.1016\/j.abb.2024.110109","volume":"759","author":"S Sun","year":"2024","unstructured":"Sun S, Zhang T, Liu L, Zhou H, Yin P, Wang L. Maresin1 restrains chronic inflammation and A\u03b2 production to ameliorate Alzheimer\u2019s disease via modulating ADAM10\/17 and its associated neuroprotective signal pathways: a pilot study. Arch Biochem Biophys. 2024;759:110109. https:\/\/doi.org\/10.1016\/j.abb.2024.110109.","journal-title":"Arch Biochem Biophys"},{"key":"400_CR165","doi-asserted-by":"publisher","first-page":"780811","DOI":"10.3389\/fnagi.2022.780811","volume":"14","author":"J Ponce","year":"2022","unstructured":"Ponce J, Ulu A, Hanson C, Cameron-Smith E, Bertoni J, Wuebker J, et al. Role of specialized pro-resolving mediators in reducing neuroinflammation in neurodegenerative disorders. Front Aging Neurosci. 2022;14:780811. https:\/\/doi.org\/10.3389\/fnagi.2022.780811.","journal-title":"Front Aging Neurosci"},{"key":"400_CR166","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener. 2015;4:19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"400_CR167","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1038\/s41467-018-05680-w","volume":"9","author":"L Maatouk","year":"2018","unstructured":"Maatouk L, Compagnion AC, Sauvage MC, Bemelmans AP, Leclere-Turbant S, Cirotteau V, et al. Author correction: TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons. Nat Commun. 2018;9(1):3109. https:\/\/doi.org\/10.1038\/s41467-018-05680-w.","journal-title":"Nat Commun"},{"key":"400_CR168","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.intimp.2017.08.008","volume":"51","author":"T Zhang","year":"2017","unstructured":"Zhang T, Xiu HH, Liu JX, Ma Y, Xu KQ, Huang WQ. Protective effect of aspirin-triggered resolvin D1 on hepatic ischemia\/reperfusion injury in rats: the role of miR-146b. Int Immunopharmacol. 2017;51:140\u20137. https:\/\/doi.org\/10.1016\/j.intimp.2017.08.008.","journal-title":"Int Immunopharmacol"},{"issue":"47","key":"400_CR169","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","volume":"42","author":"HN Ginsberg","year":"2021","unstructured":"Ginsberg HN, Packard CJ, Chapman MJ, Bor\u00e9n J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42(47):4791\u2013806. https:\/\/doi.org\/10.1093\/eurheartj\/ehab551.","journal-title":"Eur Heart J"},{"key":"400_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/nu16152430","author":"F Conti","year":"2024","unstructured":"Conti F, McCue JJ, DiTuro P, Galpin AJ, Wood TR. Mitigating traumatic brain injury: a narrative review of supplementation and dietary protocols. Nutrients. 2024. https:\/\/doi.org\/10.3390\/nu16152430.","journal-title":"Nutrients"},{"issue":"3","key":"400_CR171","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.26296","volume":"91","author":"M Nishikimi","year":"2022","unstructured":"Nishikimi M, Shoaib M, Choudhary RC, Aoki T, Miyara SJ, Yagi T, et al. Preserving brain LPC-DHA by plasma supplementation attenuates brain injury after cardiac arrest. Ann Neurol. 2022;91(3):389\u2013403. https:\/\/doi.org\/10.1002\/ana.26296.","journal-title":"Ann Neurol"},{"issue":"1","key":"400_CR172","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12974-021-02174-3","volume":"18","author":"X Xu","year":"2021","unstructured":"Xu X, Gao W, Li L, Hao J, Yang B, Wang T, et al. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia\/macrophage polarization via FPR2\/ALX-dependent AMPK-mTOR pathway. J Neuroinflammation. 2021;18(1):119. https:\/\/doi.org\/10.1186\/s12974-021-02174-3.","journal-title":"J Neuroinflammation"},{"key":"400_CR173","doi-asserted-by":"publisher","first-page":"113645","DOI":"10.1016\/j.expneurol.2021.113645","volume":"339","author":"QQ Li","year":"2021","unstructured":"Li QQ, Ding DH, Wang XY, Sun YY, Wu J. Lipoxin A4 regulates microglial M1\/M2 polarization after cerebral ischemia-reperfusion injury via the Notch signaling pathway. Exp Neurol. 2021;339:113645. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113645.","journal-title":"Exp Neurol"},{"issue":"2","key":"400_CR174","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1021\/acsnano.8b06572","volume":"13","author":"X Dong","year":"2019","unstructured":"Dong X, Gao J, Zhang CY, Hayworth C, Frank M, Wang Z. Neutrophil Membrane-Derived Nanovesicles Alleviate Inflammation To Protect Mouse Brain Injury from Ischemic Stroke. ACS Nano. 2019;13(2):1272\u201383. https:\/\/doi.org\/10.1021\/acsnano.8b06572.","journal-title":"ACS Nano"},{"issue":"6","key":"400_CR175","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3390\/molecules29061258","volume":"29","author":"E Honkisz-Orzechowska","year":"2024","unstructured":"Honkisz-Orzechowska E, \u0141a\u017cewska D, Baran G, Kie\u0107-Kononowicz K. Uncovering the power of GPR18 signalling: how RvD2 and other ligands could have the potential to modulate and resolve inflammation in various health disorders. Molecules. 2024;29(6):1258. https:\/\/doi.org\/10.3390\/molecules29061258.","journal-title":"Molecules"},{"issue":"5","key":"400_CR176","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1016\/j.clnu.2020.12.037","volume":"40","author":"Z Miao","year":"2021","unstructured":"Miao Z, Schultzberg M, Wang X, Zhao Y. Role of polyunsaturated fatty acids in ischemic stroke - a perspective of specialized pro-resolving mediators. Clin Nutr. 2021;40(5):2974\u201387. https:\/\/doi.org\/10.1016\/j.clnu.2020.12.037.","journal-title":"Clin Nutr"},{"issue":"2","key":"400_CR177","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3892\/mmr.2013.1543","volume":"8","author":"C Yao","year":"2013","unstructured":"Yao C, Zhang J, Chen F, Lin Y. Neuroprotectin D1 attenuates brain damage induced by transient middle cerebral artery occlusion in rats through TRPC6\/CREB pathways. Mol Med Rep. 2013;8(2):543\u201350. https:\/\/doi.org\/10.3892\/mmr.2013.1543.","journal-title":"Mol Med Rep"},{"issue":"12","key":"400_CR178","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41582-023-00884-1","volume":"19","author":"S Hosoki","year":"2023","unstructured":"Hosoki S, Hansra GK, Jayasena T, Poljak A, Mather KA, Catts VS, et al. Molecular biomarkers for vascular cognitive impairment and dementia. Nat Rev Neurol. 2023;19(12):737\u201353. https:\/\/doi.org\/10.1038\/s41582-023-00884-1.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"400_CR179","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s13311-021-01170-y","volume":"19","author":"T Rundek","year":"2022","unstructured":"Rundek T, Tolea M, Ariko T, Fagerli EA, Camargo CJ. Vascular cognitive impairment (VCI). Neurotherapeutics. 2022;19(1):68\u201388. https:\/\/doi.org\/10.1007\/s13311-021-01170-y.","journal-title":"Neurotherapeutics"},{"issue":"15","key":"400_CR180","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1042\/cs20201033","volume":"135","author":"E Gonzalez-Fernandez","year":"2021","unstructured":"Gonzalez-Fernandez E, Liu Y, Auchus AP, Fan F, Roman RJ. Vascular contributions to cognitive impairment and dementia: the emerging role of 20-HETE. Clin Sci Lond. 2021;135(15):1929\u201344. https:\/\/doi.org\/10.1042\/cs20201033.","journal-title":"Clin Sci Lond"},{"issue":"3","key":"400_CR181","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","volume":"27","author":"C Greene","year":"2024","unstructured":"Greene C, Connolly R, Brennan D, Laffan A, O\u2019Keeffe E, Zaporojan L, et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;27(3):421\u201332. https:\/\/doi.org\/10.1038\/s41593-024-01576-9.","journal-title":"Nat Neurosci"},{"key":"400_CR182","doi-asserted-by":"publisher","first-page":"175628641879110","DOI":"10.1177\/1756286418791107","volume":"11","author":"M Zhu","year":"2018","unstructured":"Zhu M, Wang X, Sun L, Schultzberg M, Hjorth E. Can inflammation be resolved in Alzheimer\u2019s disease? Ther Adv Neurol Disord. 2018;11:1756286418791107. https:\/\/doi.org\/10.1177\/1756286418791107.","journal-title":"Ther Adv Neurol Disord"},{"key":"400_CR183","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30102212","author":"\u00c1 Ortega","year":"2025","unstructured":"Ortega \u00c1, Duran P, Garrido B, Manzano A, Navarro C, Silva A, et al. Specialized pro-resolving lipid mediators in pulmonary diseases: molecular and therapeutic implications. Molecules. 2025. https:\/\/doi.org\/10.3390\/molecules30102212.","journal-title":"Molecules"},{"issue":"15","key":"400_CR184","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1056\/NEJMcibr2000118","volume":"382","author":"C Godson","year":"2020","unstructured":"Godson C. Balancing the effect of leukotrienes in asthma. N Engl J Med. 2020;382(15):1472\u20135. https:\/\/doi.org\/10.1056\/NEJMcibr2000118.","journal-title":"N Engl J Med"},{"issue":"1","key":"400_CR185","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.alit.2019.06.002","volume":"69","author":"J Miyata","year":"2020","unstructured":"Miyata J, Fukunaga K, Kawashima Y, Ohara O, Arita M. Cysteinyl leukotriene metabolism of human eosinophils in allergic disease. Allergol Int. 2020;69(1):28\u201334. https:\/\/doi.org\/10.1016\/j.alit.2019.06.002.","journal-title":"Allergol Int"},{"issue":"1","key":"400_CR186","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1164\/rccm.201909-1869OC","volume":"203","author":"J Kolmert","year":"2021","unstructured":"Kolmert J, G\u00f3mez C, Balgoma D, Sj\u00f6din M, Bood J, Konradsen JR, et al. Urinary leukotriene E(4) and prostaglandin D(2) metabolites increase in adult and childhood severe asthma characterized by type 2 inflammation. A clinical observational study. Am J Respir Crit Care Med. 2021;203(1):37\u201353. https:\/\/doi.org\/10.1164\/rccm.201909-1869OC.","journal-title":"Am J Respir Crit Care Med."},{"issue":"1","key":"400_CR187","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/all.14295","volume":"76","author":"M Sokolowska","year":"2021","unstructured":"Sokolowska M, Rovati GE, Diamant Z, Untersmayr E, Schwarze J, Lukasik Z, et al. Current perspective on eicosanoids in asthma and allergic diseases: EAACI task force consensus report, part I. Allergy. 2021;76(1):114\u201330. https:\/\/doi.org\/10.1111\/all.14295.","journal-title":"Allergy"},{"key":"400_CR188","doi-asserted-by":"publisher","first-page":"114759","DOI":"10.1016\/j.bcp.2021.114759","volume":"193","author":"NC Gilbert","year":"2021","unstructured":"Gilbert NC, Newcomer ME, Werz O. Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: the battle between pro- and anti-inflammatory lipid mediators. Biochem Pharmacol. 2021;193:114759. https:\/\/doi.org\/10.1016\/j.bcp.2021.114759.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"400_CR189","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/mco.0000000000000805","volume":"25","author":"RE Cagnina","year":"2022","unstructured":"Cagnina RE, Duvall MG, Nijmeh J, Levy BD. Specialized pro-resolving mediators in respiratory diseases. Curr Opin Clin Nutr Metab Care. 2022;25(2):67\u201374. https:\/\/doi.org\/10.1097\/mco.0000000000000805.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"6","key":"400_CR190","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1056\/NEJMoa021218","volume":"350","author":"SD Freedman","year":"2004","unstructured":"Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med. 2004;350(6):560\u20139. https:\/\/doi.org\/10.1056\/NEJMoa021218.","journal-title":"N Engl J Med"},{"issue":"1","key":"400_CR191","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.freeradbiomed.2012.05.001","volume":"53","author":"J Yang","year":"2012","unstructured":"Yang J, Eiserich JP, Cross CE, Morrissey BM, Hammock BD. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. Free Radic Biol Med. 2012;53(1):160\u201371. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.05.001.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"400_CR192","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1073\/pnas.1610242114","volume":"114","author":"BA Flitter","year":"2017","unstructured":"Flitter BA, Hvorecny KL, Ono E, Eddens T, Yang J, Kwak DH, et al. Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators. Proc Natl Acad Sci USA. 2017;114(1):136\u201341. https:\/\/doi.org\/10.1073\/pnas.1610242114.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"400_CR193","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/mi.2017.36","volume":"11","author":"M Codagnone","year":"2018","unstructured":"Codagnone M, Cianci E, Lamolinara A, Mari VC, Nespoli A, Isopi E, et al. Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection. Mucosal Immunol. 2018;11(1):35\u201349. https:\/\/doi.org\/10.1038\/mi.2017.36.","journal-title":"Mucosal Immunol"},{"key":"400_CR194","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3389\/fimmu.2020.00581","volume":"11","author":"E Isopi","year":"2020","unstructured":"Isopi E, Mattoscio D, Codagnone M, Mari VC, Lamolinara A, Patruno S, et al. Resolvin D1 reduces lung infection and inflammation activating resolution in cystic fibrosis. Front Immunol. 2020;11:581. https:\/\/doi.org\/10.3389\/fimmu.2020.00581.","journal-title":"Front Immunol"},{"issue":"4","key":"400_CR195","doi-asserted-by":"publisher","first-page":"Cd002201","DOI":"10.1002\/14651858.CD002201.pub6","volume":"4","author":"H Watson","year":"2020","unstructured":"Watson H, Stackhouse C. Omega-3 fatty acid supplementation for cystic fibrosis. Cochrane Database Syst Rev. 2020;4(4):Cd002201. https:\/\/doi.org\/10.1002\/14651858.CD002201.pub6.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10358","key":"400_CR196","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/s0140-6736(22)01485-4","volume":"400","author":"LDJ Bos","year":"2022","unstructured":"Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet. 2022;400(10358):1145\u201356. https:\/\/doi.org\/10.1016\/s0140-6736(22)01485-4.","journal-title":"Lancet"},{"key":"400_CR197","doi-asserted-by":"publisher","first-page":"111421","DOI":"10.1016\/j.nut.2021.111421","volume":"90","author":"E Abbasi","year":"2021","unstructured":"Abbasi E, Rezayat S, Saneei P. Comment on \u201cOmega-3 polyunsaturated fatty acids in critically ill patients with acute respiratory distress syndrome: a systematic review and meta-analysis.\u201d Nutrition. 2021;90:111421. https:\/\/doi.org\/10.1016\/j.nut.2021.111421.","journal-title":"Nutrition"},{"issue":"14","key":"400_CR198","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jama.2011.1435","volume":"306","author":"TW Rice","year":"2011","unstructured":"Rice TW, Wheeler AP, Thompson BT, deBoisblanc BP, Steingrub J, Rock P. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011;306(14):1574\u201381. https:\/\/doi.org\/10.1001\/jama.2011.1435.","journal-title":"JAMA"},{"key":"400_CR199","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.freeradbiomed.2020.07.005","volume":"156","author":"MM Rogero","year":"2020","unstructured":"Rogero MM, Le\u00e3o MC, Santana TM, Pimentel M, Carlini GCG, da Silveira TFF, et al. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Free Radic Biol Med. 2020;156:190\u20139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.07.005.","journal-title":"Free Radic Biol Med"},{"issue":"15","key":"400_CR200","doi-asserted-by":"publisher","first-page":"e148866","DOI":"10.1172\/jci.insight.148866","volume":"6","author":"B Jundi","year":"2021","unstructured":"Jundi B, Lee DH, Jeon H, Duvall MG, Nijmeh J, Abdulnour RE, et al. Inflammation resolution circuits are uncoupled in acute sepsis and correlate with clinical severity. JCI Insight. 2021;6(15):e148866. https:\/\/doi.org\/10.1172\/jci.insight.148866.","journal-title":"JCI Insight"},{"issue":"6","key":"400_CR201","doi-asserted-by":"publisher","first-page":"e21666","DOI":"10.1096\/fj.202100540R","volume":"35","author":"AS Archambault","year":"2021","unstructured":"Archambault AS, Zaid Y, Rakotoarivelo V, Turcotte C, Dor\u00e9 \u00c9, Dubuc I, et al. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients. FASEB J. 2021;35(6):e21666. https:\/\/doi.org\/10.1096\/fj.202100540R.","journal-title":"FASEB J"},{"issue":"4","key":"400_CR202","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1161\/circresaha.121.319142","volume":"129","author":"DS Koenis","year":"2021","unstructured":"Koenis DS, Beegun I, Jouvene CC, Aguirre GA, Souza PR, Gonzalez-Nunez M, et al. Disrupted resolution mechanisms favor altered phagocyte responses in COVID-19. Circ Res. 2021;129(4):e54\u201371. https:\/\/doi.org\/10.1161\/circresaha.121.319142.","journal-title":"Circ Res"},{"issue":"2","key":"400_CR203","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4049\/jimmunol.2001025","volume":"206","author":"B Schwarz","year":"2021","unstructured":"Schwarz B, Sharma L, Roberts L, Peng X, Bermejo S, Leighton I, et al. Cutting edge: Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome, resulting in dysregulation of eicosanoid immune mediators. J Immunol. 2021;206(2):329\u201334. https:\/\/doi.org\/10.4049\/jimmunol.2001025.","journal-title":"J Immunol"},{"issue":"1","key":"400_CR204","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1096\/fj.201902126R","volume":"34","author":"N Rymut","year":"2020","unstructured":"Rymut N, Heinz J, Sadhu S, Hosseini Z, Riley CO, Marinello M, et al. Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage. FASEB J. 2020;34(1):597\u2013609. https:\/\/doi.org\/10.1096\/fj.201902126R.","journal-title":"FASEB J"},{"issue":"3","key":"400_CR205","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/all.14595","volume":"76","author":"E Andreakos","year":"2021","unstructured":"Andreakos E, Papadaki M, Serhan CN. Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19. Allergy. 2021;76(3):626\u20138. https:\/\/doi.org\/10.1111\/all.14595.","journal-title":"Allergy"},{"key":"400_CR206","doi-asserted-by":"publisher","first-page":"624657","DOI":"10.3389\/fphys.2020.624657","volume":"11","author":"H Arnardottir","year":"2020","unstructured":"Arnardottir H, Pawelzik SC, \u00d6hlund Wistbacka U, Artiach G, Hofmann R, Reinholdsson I, et al. Stimulating the resolution of inflammation through omega-3 polyunsaturated fatty acids in COVID-19: rationale for the COVID-Omega-F trial. Front Physiol. 2020;11:624657. https:\/\/doi.org\/10.3389\/fphys.2020.624657.","journal-title":"Front Physiol"},{"key":"400_CR207","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.pharmthera.2019.02.001","volume":"197","author":"TH Thatcher","year":"2019","unstructured":"Thatcher TH, Woeller CF, McCarthy CE, Sime PJ. Quenching the fires: pro-resolving mediators, air pollution, and smoking. Pharmacol Ther. 2019;197:212\u201324. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.02.001.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"400_CR208","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bbalip.2018.11.012","volume":"1864","author":"AM van der Does","year":"2019","unstructured":"van der Does AM, Heijink M, Mayboroda OA, Persson LJ, Aanerud M, Bakke P, et al. Dynamic differences in dietary polyunsaturated fatty acid metabolism in sputum of COPD patients and controls. Biochimica et Biophysica Acta (BBA). 2019;1864(3):224\u201333. https:\/\/doi.org\/10.1016\/j.bbalip.2018.11.012.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"Suppl 2","key":"400_CR209","doi-asserted-by":"publisher","first-page":"s102","DOI":"10.1136\/tobaccocontrol-2019-054958","volume":"29","author":"NA Khan","year":"2020","unstructured":"Khan NA, Lawyer G, McDonough S, Wang Q, Kassem NO, Kas-Petrus F, et al. Systemic biomarkers of inflammation, oxidative stress and tissue injury and repair among waterpipe, cigarette and dual tobacco smokers. Tob Control. 2020;29(Suppl 2):s102\u20139. https:\/\/doi.org\/10.1136\/tobaccocontrol-2019-054958.","journal-title":"Tob Control"},{"key":"400_CR210","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00182-2019","author":"KP Singh","year":"2019","unstructured":"Singh KP, Lawyer G, Muthumalage T, Maremanda KP, Khan NA, McDonough SR, et al. Systemic biomarkers in electronic cigarette users: implications for noninvasive assessment of vaping-associated pulmonary injuries. ERJ Open Res. 2019. https:\/\/doi.org\/10.1183\/23120541.00182-2019.","journal-title":"ERJ Open Res"},{"issue":"6","key":"400_CR211","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.4049\/jimmunol.2001228","volume":"206","author":"TA Bhat","year":"2021","unstructured":"Bhat TA, Kalathil SG, Bogner PN, Lehmann PV, Thatcher TH, Sime PJ, et al. AT-RvD1 mitigates secondhand smoke-exacerbated pulmonary inflammation and restores secondhand smoke-suppressed antibacterial immunity. J Immunol. 2021;206(6):1348\u201360. https:\/\/doi.org\/10.4049\/jimmunol.2001228.","journal-title":"J Immunol"},{"issue":"2","key":"400_CR212","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/toxsci\/kfy040","volume":"163","author":"B Kilburg-Basnyat","year":"2018","unstructured":"Kilburg-Basnyat B, Reece SW, Crouch MJ, Luo B, Boone AD, Yaeger M, et al. Specialized pro-resolving lipid mediators regulate ozone-induced pulmonary and systemic inflammation. Toxicol Sci. 2018;163(2):466\u201377. https:\/\/doi.org\/10.1093\/toxsci\/kfy040.","journal-title":"Toxicol Sci"},{"issue":"1","key":"400_CR213","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/toxsci\/kfab081","volume":"183","author":"MJ Yaeger","year":"2021","unstructured":"Yaeger MJ, Reece SW, Kilburg-Basnyat B, Hodge MX, Pal A, Dunigan-Russell K, et al. Sex differences in pulmonary eicosanoids and specialized pro-resolving mediators in response to ozone exposure. Toxicol Sci. 2021;183(1):170\u201383. https:\/\/doi.org\/10.1093\/toxsci\/kfab081.","journal-title":"Toxicol Sci"},{"key":"400_CR214","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3389\/fimmu.2020.01186","volume":"11","author":"CS Lim","year":"2020","unstructured":"Lim CS, Porter DW, Orandle MS, Green BJ, Barnes MA, Croston TL, et al. Resolution of pulmonary inflammation induced by carbon nanotubes and fullerenes in mice: role of macrophage polarization. Front Immunol. 2020;11:1186. https:\/\/doi.org\/10.3389\/fimmu.2020.01186.","journal-title":"Front Immunol"},{"key":"400_CR215","doi-asserted-by":"publisher","first-page":"108797","DOI":"10.1016\/j.jnutbio.2021.108797","volume":"97","author":"A Ulu","year":"2021","unstructured":"Ulu A, Burr A, Heires AJ, Pavlik J, Larsen T, Perez PA, et al. A high docosahexaenoic acid diet alters lung inflammation and recovery following repetitive exposure to aqueous organic dust extracts. J Nutr Biochem. 2021;97:108797. https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108797.","journal-title":"J Nutr Biochem"},{"issue":"3","key":"400_CR216","doi-asserted-by":"publisher","first-page":"448","DOI":"10.21037\/jtd.2017.02.75","volume":"9","author":"H Nagai","year":"2017","unstructured":"Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis. 2017;9(3):448\u201351. https:\/\/doi.org\/10.21037\/jtd.2017.02.75.","journal-title":"J Thorac Dis"},{"key":"400_CR217","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41420-020-0255-6","volume":"6","author":"C Brostjan","year":"2020","unstructured":"Brostjan C, Oehler R. The role of neutrophil death in chronic inflammation and cancer. Cell Death Discov. 2020;6:26. https:\/\/doi.org\/10.1038\/s41420-020-0255-6.","journal-title":"Cell Death Discov"},{"issue":"21","key":"400_CR218","doi-asserted-by":"publisher","first-page":"10823","DOI":"10.1039\/d4fo03859b","volume":"15","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Xu J, Zhao Y, Niu Y. Relationships of dietary habits with prostate cancer risk: results from Mendelian randomization analyses and the National Health and Nutrition Examination Survey. Food Funct. 2024;15(21):10823\u201337. https:\/\/doi.org\/10.1039\/d4fo03859b.","journal-title":"Food Funct"},{"issue":"4","key":"400_CR219","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3390\/ijms21041447","volume":"21","author":"M Matsushita","year":"2020","unstructured":"Matsushita M, Fujita K, Nonomura N. Influence of diet and nutrition on prostate cancer. Int J Mol Sci. 2020;21(4):1447. https:\/\/doi.org\/10.3390\/ijms21041447.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"400_CR220","doi-asserted-by":"publisher","first-page":"12623","DOI":"10.3390\/ijms241612623","volume":"24","author":"W Torres","year":"2023","unstructured":"Torres W, P\u00e9rez JL, D\u00edaz MP, D\u2019Marco L, Checa-Ros A, Carrasquero R, et al. The role of specialized pro-resolving lipid mediators in inflammation-induced carcinogenesis. Int J Mol Sci. 2023;24(16):12623. https:\/\/doi.org\/10.3390\/ijms241612623.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"400_CR221","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41574-024-01047-y","volume":"21","author":"M Sot\u00e1k","year":"2025","unstructured":"Sot\u00e1k M, Clark M, Suur BE, B\u00f6rgeson E. Inflammation and resolution in obesity. Nat Rev Endocrinol. 2025;21(1):45\u201361. https:\/\/doi.org\/10.1038\/s41574-024-01047-y.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"400_CR222","doi-asserted-by":"publisher","first-page":"e2412551","DOI":"10.1002\/advs.202412551","volume":"12","author":"R Sun","year":"2025","unstructured":"Sun R, Zhang Y, Zhao X, Tang T, Cao Y, Yang L, et al. Temporal and spatial metabolic shifts revealing the transition from ulcerative colitis to colitis-associated colorectal cancer. Adv Sci. 2025;12(11):e2412551. https:\/\/doi.org\/10.1002\/advs.202412551.","journal-title":"Adv Sci"},{"key":"400_CR223","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pharmthera.2018.07.006","volume":"193","author":"Y Hisano","year":"2019","unstructured":"Hisano Y, Hla T. Bioactive lysolipids in cancer and angiogenesis. Pharmacol Ther. 2019;193:91\u20138. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.07.006.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"400_CR224","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.trsl.2015.02.009","volume":"166","author":"A Marginean","year":"2015","unstructured":"Marginean A, Sharma-Walia N. Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi\u2019s sarcoma cells. Transl Res. 2015;166(2):111\u201333. https:\/\/doi.org\/10.1016\/j.trsl.2015.02.009.","journal-title":"Transl Res"},{"issue":"8","key":"400_CR225","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1158\/1535-7163.Mct-10-0173","volume":"9","author":"Y Chen","year":"2010","unstructured":"Chen Y, Hao H, He S, Cai L, Li Y, Hu S, et al. Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Mol Cancer Ther. 2010;9(8):2164\u201374. https:\/\/doi.org\/10.1158\/1535-7163.Mct-10-0173.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"400_CR226","doi-asserted-by":"publisher","first-page":"e1293213","DOI":"10.1080\/2162402x.2017.1293213","volume":"6","author":"N Prevete","year":"2017","unstructured":"Prevete N, Liotti F, Illiano A, Amoresano A, Pucci P, de Paulis A, et al. Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways. Oncoimmunology. 2017;6(4):e1293213. https:\/\/doi.org\/10.1080\/2162402x.2017.1293213.","journal-title":"Oncoimmunology"},{"issue":"3","key":"400_CR227","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4049\/jimmunol.1003456","volume":"186","author":"NK Rajasagi","year":"2011","unstructured":"Rajasagi NK, Reddy PB, Suryawanshi A, Mulik S, Gjorstrup P, Rouse BT. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J Immunol. 2011;186(3):1735\u201346. https:\/\/doi.org\/10.4049\/jimmunol.1003456.","journal-title":"J Immunol"},{"key":"400_CR228","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, et al. Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126\u201333. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.009.","journal-title":"Cancer Lett"},{"issue":"4","key":"400_CR229","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/vaccines4040046","volume":"4","author":"NE Scharping","year":"2016","unstructured":"Scharping NE, Delgoffe GM. Tumor microenvironment metabolism: a new checkpoint for anti-tumor immunity. Vaccines. 2016;4(4):46. https:\/\/doi.org\/10.3390\/vaccines4040046.","journal-title":"Vaccines"},{"key":"400_CR230","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fimmu.2017.00071","volume":"8","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Zhu B, Li Y. Resolution of cancer-promoting inflammation: a new approach for anticancer therapy. Front Immunol. 2017;8:71. https:\/\/doi.org\/10.3389\/fimmu.2017.00071.","journal-title":"Front Immunol"},{"issue":"19","key":"400_CR231","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.7150\/jca.32456","volume":"10","author":"H Liu","year":"2019","unstructured":"Liu H, Zeng J, Huang W, Xu Q, Ye D, Sun R, et al. Colorectal cancer is associated with a deficiency of lipoxin A(4), an endogenous anti-inflammatory mediator. J Cancer. 2019;10(19):4719\u201330. https:\/\/doi.org\/10.7150\/jca.32456.","journal-title":"J Cancer"},{"key":"400_CR232","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3389\/fonc.2019.00540","volume":"9","author":"NM de-Brito","year":"2019","unstructured":"de-Brito NM, da-Costa HC, Sim\u00f5es RL, Barja-Fidalgo C. Lipoxin-induced phenotypic changes in CD115(+)LY6C(hi) monocytes TAM precursors inhibits tumor development. Front Oncol. 2019;9:540. https:\/\/doi.org\/10.3389\/fonc.2019.00540.","journal-title":"Front Oncol"},{"issue":"2","key":"400_CR233","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/ijc.30424","volume":"140","author":"RL Sim\u00f5es","year":"2017","unstructured":"Sim\u00f5es RL, De-Brito NM, Cunha-Costa H, Morandi V, Fierro IM, Roitt IM, et al. Lipoxin A(4) selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression. Int J Cancer. 2017;140(2):346\u201357. https:\/\/doi.org\/10.1002\/ijc.30424.","journal-title":"Int J Cancer"},{"issue":"3\u20134","key":"400_CR234","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10555-011-9311-2","volume":"30","author":"NB Janakiram","year":"2011","unstructured":"Janakiram NB, Mohammed A, Rao CV. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer Metastasis Rev. 2011;30(3\u20134):507\u201323. https:\/\/doi.org\/10.1007\/s10555-011-9311-2.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"400_CR235","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1073\/pnas.0907342107","volume":"107","author":"S Krishnamoorthy","year":"2010","unstructured":"Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A. 2010;107(4):1660\u20135. https:\/\/doi.org\/10.1073\/pnas.0907342107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"400_CR236","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.canlet.2015.04.030","volume":"364","author":"Z Wang","year":"2015","unstructured":"Wang Z, Cheng Q, Tang K, Sun Y, Zhang K, Zhang Y, et al. Lipid mediator lipoxin A4 inhibits tumor growth by targeting IL-10-producing regulatory B (Breg) cells. Cancer Lett. 2015;364(2):118\u201324. https:\/\/doi.org\/10.1016\/j.canlet.2015.04.030.","journal-title":"Cancer Lett"},{"issue":"3","key":"400_CR237","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","volume":"18","author":"N Singh","year":"2019","unstructured":"Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, Pujari VB. Inflammation and cancer. Ann Afr Med. 2019;18(3):121\u20136. https:\/\/doi.org\/10.4103\/aam.aam_56_18.","journal-title":"Ann Afr Med"},{"issue":"12","key":"400_CR238","doi-asserted-by":"publisher","first-page":"a026542","DOI":"10.1101\/cshperspect.a026542","volume":"7","author":"K Curtius","year":"2017","unstructured":"Curtius K, Wright NA, Graham TA. Evolution of premalignant disease. Cold Spring Harb Perspect Med. 2017;7(12):a026542. https:\/\/doi.org\/10.1101\/cshperspect.a026542.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"400_CR239","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1158\/1940-6207.Capr-16-0209","volume":"9","author":"J Todoric","year":"2016","unstructured":"Todoric J, Antonucci L, Karin M. Targeting inflammation in cancer prevention and therapy. Cancer Prev Res (Phila). 2016;9(12):895\u2013905. https:\/\/doi.org\/10.1158\/1940-6207.Capr-16-0209.","journal-title":"Cancer Prev Res (Phila)"},{"key":"400_CR240","doi-asserted-by":"publisher","DOI":"10.3390\/biom9090476","author":"CJ Li","year":"2019","unstructured":"Li CJ, Chu PY, Yiang GT, Wu MY. The molecular mechanism of epithelial-mesenchymal transition for breast carcinogenesis. Biomolecules. 2019. https:\/\/doi.org\/10.3390\/biom9090476.","journal-title":"Biomolecules"},{"issue":"1","key":"400_CR241","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13046-017-0655-5","volume":"36","author":"L Zong","year":"2017","unstructured":"Zong L, Chen K, Jiang Z, Chen X, Sun L, Ma J, et al. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-\u03b21 signaling in pancreatic cancer. J Exp Clin Cancer Res. 2017;36(1):181. https:\/\/doi.org\/10.1186\/s13046-017-0655-5.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"400_CR242","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13046-019-1163-6","volume":"38","author":"L Sun","year":"2019","unstructured":"Sun L, Wang Y, Wang L, Yao B, Chen T, Li Q, et al. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP. J Exp Clin Cancer Res. 2019;38(1):170. https:\/\/doi.org\/10.1186\/s13046-019-1163-6.","journal-title":"J Exp Clin Cancer Res"},{"key":"400_CR243","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.prostaglandins.2017.01.002","volume":"132","author":"R Tian","year":"2017","unstructured":"Tian R, Zuo X, Jaoude J, Mao F, Colby J, Shureiqi I. ALOX15 as a suppressor of inflammation and cancer: lost in the link. Prostaglandins Other Lipid Mediat. 2017;132:77\u201383. https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.01.002.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"400_CR244","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3892\/or.2015.4389","volume":"35","author":"H Kuang","year":"2016","unstructured":"Kuang H, Hua X, Zhou J, Yang R. Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-\u03baB activity. Oncol Rep. 2016;35(1):307\u201317. https:\/\/doi.org\/10.3892\/or.2015.4389.","journal-title":"Oncol Rep"},{"key":"400_CR245","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2019.11.033","volume":"147","author":"P Zhang","year":"2020","unstructured":"Zhang P, Yin Y, Wang T, Li W, Li C, Zeng X, et al. Maresin 1 mitigates concanavalin A-induced acute liver injury in mice by inhibiting ROS-mediated activation of NF-\u03baB signaling. Free Radic Biol Med. 2020;147:23\u201336. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.11.033.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"400_CR246","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.3892\/mmr.2016.4980","volume":"13","author":"J Ren","year":"2016","unstructured":"Ren J, Meng S, Yan B, Yu J, Liu J. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-\u03baB-mediated CX3CL1\/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation. Mol Med Rep. 2016;13(4):3627\u201338. https:\/\/doi.org\/10.3892\/mmr.2016.4980.","journal-title":"Mol Med Rep"},{"issue":"5b","key":"400_CR247","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1582-4934.2008.00387.x","volume":"12","author":"P Anderson","year":"2008","unstructured":"Anderson P, Delgado M. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders. J Cell Mol Med. 2008;12(5b):1830\u201347. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00387.x.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"400_CR248","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.3390\/ijms21093074","volume":"21","author":"MD Cas","year":"2020","unstructured":"Cas MD, Roda G, Li F, Secundo F. Functional lipids in autoimmune inflammatory diseases. Int J Mol Sci. 2020;21(9):3074. https:\/\/doi.org\/10.3390\/ijms21093074.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"400_CR249","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.scib.2024.07.049","volume":"70","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Wang Y, Zhu J, Zou M, Zhang Y, Wu H, et al. Specialized pro-resolving lipid mediators: a key player in resolving inflammation in autoimmune diseases. Sci Bull (Beijing). 2025;70(5):778\u201394. https:\/\/doi.org\/10.1016\/j.scib.2024.07.049.","journal-title":"Sci Bull (Beijing)"},{"issue":"6","key":"400_CR250","doi-asserted-by":"publisher","first-page":"e2077","DOI":"10.1002\/rmv.2077","volume":"29","author":"D Focosi","year":"2019","unstructured":"Focosi D, Tuccori M, Maggi F. Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: what do we know after 20 years of rituximab. Rev Med Virol. 2019;29(6):e2077. https:\/\/doi.org\/10.1002\/rmv.2077.","journal-title":"Rev Med Virol"},{"issue":"11","key":"400_CR251","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/annrheumdis-2019-215920","volume":"78","author":"S Safiri","year":"2019","unstructured":"Safiri S, Kolahi AA, Hoy D, Smith E, Bettampadi D, Mansournia MA, et al. Global, regional and national burden of rheumatoid arthritis 1990\u20132017: a systematic analysis of the Global Burden of Disease study 2017. Ann Rheum Dis. 2019;78(11):1463\u201371. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215920.","journal-title":"Ann Rheum Dis"},{"key":"400_CR252","doi-asserted-by":"publisher","unstructured":"Cecchi I, Arias de la Rosa I, Menegatti E, Roccatello D, Collantes-Estevez E, Lopez-Pedrera C, et al. Neutrophils: Novel key players in Rheumatoid Arthritis Current and future therapeutic targets. Autoimmun Rev. 2018;17(11):1138\u201349. https:\/\/doi.org\/10.1016\/j.autrev.2018.06.006.","DOI":"10.1016\/j.autrev.2018.06.006"},{"issue":"2","key":"400_CR253","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1124\/pr.114.009639","volume":"67","author":"S Siebert","year":"2015","unstructured":"Siebert S, Tsoukas A, Robertson J, McInnes I. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Pharmacol Rev. 2015;67(2):280\u2013309. https:\/\/doi.org\/10.1124\/pr.114.009639.","journal-title":"Pharmacol Rev"},{"issue":"6","key":"400_CR254","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.4049\/jimmunol.1502268","volume":"197","author":"HH Arnardottir","year":"2016","unstructured":"Arnardottir HH, Dalli J, Norling LV, Colas RA, Perretti M, Serhan CN. Resolvin D3 is dysregulated in arthritis and reduces arthritic inflammation. J Immunol. 2016;197(6):2362\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1502268.","journal-title":"J Immunol"},{"issue":"3","key":"400_CR255","doi-asserted-by":"publisher","first-page":"e85922","DOI":"10.1172\/jci.insight.168728","volume":"8","author":"LV Norling","year":"2023","unstructured":"Norling LV, Headland SE, Dalli J, Arnardottir HH, Haworth O, Jones HR, et al. Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis. JCI Insight. 2023;8(3):e85922. https:\/\/doi.org\/10.1172\/jci.insight.168728.","journal-title":"JCI Insight"},{"issue":"1","key":"400_CR256","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1172\/jci131609","volume":"130","author":"MB Flak","year":"2020","unstructured":"Flak MB, Koenis DS, Sobrino A, Smith J, Pistorius K, Palmas F, et al. GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections. J Clin Invest. 2020;130(1):359\u201373. https:\/\/doi.org\/10.1172\/jci131609.","journal-title":"J Clin Invest"},{"key":"400_CR257","doi-asserted-by":"publisher","first-page":"103974","DOI":"10.1016\/j.ebiom.2022.103974","volume":"79","author":"K Pistorius","year":"2022","unstructured":"Pistorius K, Ly L, Souza PR, Gomez EA, Koenis DS, Rodriguez AR, et al. MCTR3 reprograms arthritic monocytes to upregulate Arginase-1 and exert pro-resolving and tissue-protective functions in experimental arthritis. EBioMedicine. 2022;79:103974. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103974.","journal-title":"EBioMedicine"},{"issue":"1","key":"400_CR258","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13075-019-1852-8","volume":"21","author":"HA Benabdoun","year":"2019","unstructured":"Benabdoun HA, Kulbay M, Rondon EP, Valli\u00e8res F, Shi Q, Fernandes J, et al. In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis. Arthritis Res Ther. 2019;21(1):72. https:\/\/doi.org\/10.1186\/s13075-019-1852-8.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"400_CR259","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1097\/j.pain.0000000000001908","volume":"161","author":"BL Allen","year":"2020","unstructured":"Allen BL, Montague-Cardoso K, Simeoli R, Colas RA, Oggero S, Vilar B, et al. Imbalance of proresolving lipid mediators in persistent allodynia dissociated from signs of clinical arthritis. Pain. 2020;161(9):2155\u201366. https:\/\/doi.org\/10.1097\/j.pain.0000000000001908.","journal-title":"Pain"},{"issue":"6","key":"400_CR260","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/wco.0000000000000622","volume":"31","author":"J Oh","year":"2018","unstructured":"Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018;31(6):752\u20139. https:\/\/doi.org\/10.1097\/wco.0000000000000622.","journal-title":"Curr Opin Neurol"},{"issue":"13","key":"400_CR261","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.cell.2022.05.020","volume":"185","author":"K Shi","year":"2022","unstructured":"Shi K, Li H, Chang T, He W, Kong Y, Qi C, et al. Bone marrow hematopoiesis drives multiple sclerosis progression. Cell. 2022;185(13):2234-47.e17. https:\/\/doi.org\/10.1016\/j.cell.2022.05.020.","journal-title":"Cell"},{"issue":"8","key":"400_CR262","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3324\/haematol.2019.219519","volume":"105","author":"G Kooij","year":"2020","unstructured":"Kooij G, Troletti CD, Leuti A, Norris PC, Riley I, Albanese M, et al. Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction. Haematologica. 2020;105(8):2056\u201370. https:\/\/doi.org\/10.3324\/haematol.2019.219519.","journal-title":"Haematologica"},{"issue":"52","key":"400_CR263","doi-asserted-by":"publisher","first-page":"30697","DOI":"10.1074\/jbc.M115.679068","volume":"290","author":"LM Poisson","year":"2015","unstructured":"Poisson LM, Suhail H, Singh J, Datta I, Denic A, Labuzek K, et al. Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis. J Biol Chem. 2015;290(52):30697\u2013712. https:\/\/doi.org\/10.1074\/jbc.M115.679068.","journal-title":"J Biol Chem"},{"issue":"2","key":"400_CR264","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055859","volume":"8","author":"H Pr\u00fcss","year":"2013","unstructured":"Pr\u00fcss H, Rosche B, Sullivan AB, Brommer B, Wengert O, Gronert K, et al. Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial. PLoS ONE. 2013;8(2):e55859. https:\/\/doi.org\/10.1371\/journal.pone.0055859.","journal-title":"PLoS ONE"},{"key":"400_CR265","doi-asserted-by":"publisher","unstructured":"Tu\u0142owiecka N, Kotl\u0119ga D, Bohatyrewicz A, Szczuko M. Could Lipoxins Represent a New Standard in Ischemic Stroke Treatment? Int J Mol Sci. 2021;22(8). https:\/\/doi.org\/10.3390\/ijms22084207.","DOI":"10.3390\/ijms22084207"},{"issue":"3","key":"400_CR266","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","volume":"41","author":"K Yasuda","year":"2019","unstructured":"Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol. 2019;41(3):283\u201397. https:\/\/doi.org\/10.1007\/s00281-019-00733-8.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"400_CR267","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02386-1","volume":"19","author":"A S\u00e1nchez-Fern\u00e1ndez","year":"2022","unstructured":"S\u00e1nchez-Fern\u00e1ndez A, Zandee S, Mastrogiovanni M, Charabati M, Rubbo H, Prat A, et al. Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis. J Neuroinflammation. 2022;19(1):27. https:\/\/doi.org\/10.1186\/s12974-022-02386-1.","journal-title":"J Neuroinflammation"},{"key":"400_CR268","doi-asserted-by":"publisher","first-page":"107879","DOI":"10.1016\/j.pharmthera.2021.107879","volume":"227","author":"D Panigrahy","year":"2021","unstructured":"Panigrahy D, Gilligan MM, Serhan CN, Kashfi K. Resolution of inflammation: an organizing principle in biology and medicine. Pharmacol Ther. 2021;227:107879. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107879.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"400_CR269","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41575-022-00593-y","volume":"19","author":"M Agrawal","year":"2022","unstructured":"Agrawal M, Allin KH, Petralia F, Colombel JF, Jess T. Multiomics to elucidate inflammatory bowel disease risk factors and pathways. Nat Rev Gastroenterol Hepatol. 2022;19(6):399\u2013409. https:\/\/doi.org\/10.1038\/s41575-022-00593-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"32","key":"400_CR270","doi-asserted-by":"publisher","first-page":"14298","DOI":"10.1073\/pnas.0914730107","volume":"107","author":"EL Campbell","year":"2010","unstructured":"Campbell EL, MacManus CF, Kominsky DJ, Keely S, Glover LE, Bowers BE, et al. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proc Natl Acad Sci USA. 2010;107(32):14298\u2013303. https:\/\/doi.org\/10.1073\/pnas.0914730107.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"400_CR271","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.4049\/jimmunol.1101305","volume":"187","author":"AF Bento","year":"2011","unstructured":"Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J Immunol. 2011;187(4):1957\u201369. https:\/\/doi.org\/10.4049\/jimmunol.1101305.","journal-title":"J Immunol"},{"issue":"8","key":"400_CR272","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.4049\/jimmunol.1202743","volume":"191","author":"R Marcon","year":"2013","unstructured":"Marcon R, Bento AF, Dutra RC, Bicca MA, Leite DF, Calixto JB. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis. J Immunol. 2013;191(8):4288\u201398. https:\/\/doi.org\/10.4049\/jimmunol.1202743.","journal-title":"J Immunol"},{"issue":"12","key":"400_CR273","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.autrev.2016.09.004","volume":"15","author":"M Sticherling","year":"2016","unstructured":"Sticherling M. Psoriasis and autoimmunity. Autoimmun Rev. 2016;15(12):1167\u201370. https:\/\/doi.org\/10.1016\/j.autrev.2016.09.004.","journal-title":"Autoimmun Rev"},{"key":"400_CR274","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054901","author":"AB Azuaga","year":"2023","unstructured":"Azuaga AB, Ram\u00edrez J, Ca\u00f1ete JD. Psoriatic arthritis: pathogenesis and targeted therapies. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24054901.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"400_CR275","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt A, Chiricozzi A. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin Rev Allergy Immunol. 2018;55(3):379\u201390. https:\/\/doi.org\/10.1007\/s12016-018-8702-3.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"400_CR276","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jacl.2018.03.091","volume":"12","author":"AV Sorokin","year":"2018","unstructured":"Sorokin AV, Norris PC, English JT, Dey AK, Chaturvedi A, Baumer Y, et al. Identification of proresolving and inflammatory lipid mediators in human psoriasis. J Clin Lipidol. 2018;12(4):1047\u201360. https:\/\/doi.org\/10.1016\/j.jacl.2018.03.091.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"400_CR277","doi-asserted-by":"publisher","first-page":"11873","DOI":"10.1038\/s41598-018-30373-1","volume":"8","author":"Y Sawada","year":"2018","unstructured":"Sawada Y, Honda T, Nakamizo S, Otsuka A, Ogawa N, Kobayashi Y, et al. Resolvin E1 attenuates murine psoriatic dermatitis. Sci Rep. 2018;8(1):11873. https:\/\/doi.org\/10.1038\/s41598-018-30373-1.","journal-title":"Sci Rep"},{"issue":"1","key":"400_CR278","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1038\/s41598-018-23623-9","volume":"8","author":"N Saito-Sasaki","year":"2018","unstructured":"Saito-Sasaki N, Sawada Y, Mashima E, Yamaguchi T, Ohmori S, Yoshioka H, et al. Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression. Sci Rep. 2018;8(1):5522. https:\/\/doi.org\/10.1038\/s41598-018-23623-9.","journal-title":"Sci Rep"},{"issue":"26","key":"400_CR279","doi-asserted-by":"publisher","first-page":"12111","DOI":"10.7150\/thno.52135","volume":"10","author":"SH Lee","year":"2020","unstructured":"Lee SH, Tonello R, Im ST, Jeon H, Park J, Ford Z, et al. Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis. Theranostics. 2020;10(26):12111\u201326. https:\/\/doi.org\/10.7150\/thno.52135.","journal-title":"Theranostics"},{"issue":"3","key":"400_CR280","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","volume":"17","author":"BO Roep","year":"2021","unstructured":"Roep BO, Thomaidou S, van Tienhoven R, Zaldumbide A. Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?). Nat Rev Endocrinol. 2021;17(3):150\u201361. https:\/\/doi.org\/10.1038\/s41574-020-00443-4.","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"400_CR281","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/s0006-2952(97)00492-9","volume":"55","author":"A Rabinovitch","year":"1998","unstructured":"Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol. 1998;55(8):1139\u201349. https:\/\/doi.org\/10.1016\/s0006-2952(97)00492-9.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"400_CR282","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/ajcn\/78.6.1128","volume":"78","author":"LC Stene","year":"2003","unstructured":"Stene LC, Joner G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr. 2003;78(6):1128\u201334. https:\/\/doi.org\/10.1093\/ajcn\/78.6.1128.","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"400_CR283","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3390\/nu11123055","volume":"11","author":"S S\u00e1nchez-Hern\u00e1ndez","year":"2019","unstructured":"S\u00e1nchez-Hern\u00e1ndez S, Esteban-Mu\u00f1oz A, Gim\u00e9nez-Mart\u00ednez R, Aguilar-Cordero MJ, Miralles-Buraglia B, Olalla-Herrera M. A comparison of changes in the fatty acid profile of human milk of spanish lactating women during the first month of lactation using gas chromatography-mass spectrometry. A Comparison with Infant Formulas. Nutrients. 2019;11(12):3055. https:\/\/doi.org\/10.3390\/nu11123055.","journal-title":"Nutrients"},{"issue":"4","key":"400_CR284","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.2337\/db10-0901","volume":"60","author":"J Bellenger","year":"2011","unstructured":"Bellenger J, Bellenger S, Bataille A, Massey KA, Nicolaou A, Rialland M, et al. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes. 2011;60(4):1090\u20139. https:\/\/doi.org\/10.2337\/db10-0901.","journal-title":"Diabetes"},{"issue":"4","key":"400_CR285","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3390\/ijms22041516","volume":"22","author":"S Bathina","year":"2021","unstructured":"Bathina S, Das UN. Resolvin D1 decreases severity of streptozotocin-induced type 1 diabetes mellitus by enhancing bdnf levels, reducing oxidative stress, and suppressing inflammation. Int J Mol Sci. 2021;22(4):1516. https:\/\/doi.org\/10.3390\/ijms22041516.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"400_CR286","doi-asserted-by":"publisher","first-page":"103673","DOI":"10.1016\/j.autrev.2024.103673","volume":"23","author":"C Perricone","year":"2024","unstructured":"Perricone C, Bruno L, Cafaro G, Latini A, Ceccarelli F, Borgiani P, et al. Sjogren\u2019s syndrome: everything you always wanted to know about genetic and epigenetic factors. Autoimmun Rev. 2024;23(12):103673. https:\/\/doi.org\/10.1016\/j.autrev.2024.103673.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"400_CR287","doi-asserted-by":"publisher","first-page":"7733","DOI":"10.1096\/fj.201902196R","volume":"34","author":"K Parashar","year":"2020","unstructured":"Parashar K, Schulte F, Hardt M, Baker OJ. Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sj\u00f6gren\u2019s syndrome mouse model. FASEB J. 2020;34(6):7733\u201344. https:\/\/doi.org\/10.1096\/fj.201902196R.","journal-title":"FASEB J"},{"issue":"7","key":"400_CR288","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/rheumatology\/kez072","volume":"58","author":"S Dean","year":"2019","unstructured":"Dean S, Wang CS, Nam K, Maruyama CL, Trump BG, Baker OJ. Aspirin triggered resolvin D1 reduces inflammation and restores saliva secretion in a Sj\u00f6gren\u2019s syndrome mouse model. Rheumatology (Oxford). 2019;58(7):1285\u201392. https:\/\/doi.org\/10.1093\/rheumatology\/kez072.","journal-title":"Rheumatology (Oxford)"},{"issue":"19","key":"400_CR289","doi-asserted-by":"publisher","first-page":"e12990","DOI":"10.14814\/phy2.12990","volume":"4","author":"JT Easley","year":"2016","unstructured":"Easley JT, Maruyama CL, Wang CS, Baker OJ. AT-RvD1 combined with DEX is highly effective in treating TNF-\u03b1-mediated disruption of the salivary gland epithelium. Physiol Rep. 2016;4(19):e12990. https:\/\/doi.org\/10.14814\/phy2.12990.","journal-title":"Physiol Rep"},{"issue":"10","key":"400_CR290","doi-asserted-by":"publisher","first-page":"e30330","DOI":"10.7759\/cureus.30330","volume":"14","author":"MA Ameer","year":"2022","unstructured":"Ameer MA, Chaudhry H, Mushtaq J, Khan OS, Babar M, Hashim T, et al. An overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, classification, and management. Cureus. 2022;14(10):e30330. https:\/\/doi.org\/10.7759\/cureus.30330.","journal-title":"Cureus"},{"issue":"4","key":"400_CR291","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1007\/s00415-019-09489-5","volume":"268","author":"H Inojosa","year":"2021","unstructured":"Inojosa H, Proschmann U, Akg\u00fcn K, Ziemssen T. A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition. J Neurol. 2021;268(4):1210\u201321. https:\/\/doi.org\/10.1007\/s00415-019-09489-5.","journal-title":"J Neurol"},{"issue":"16","key":"400_CR292","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1002\/1873-3468.13215","volume":"592","author":"Y Unno","year":"2018","unstructured":"Unno Y, Sato Y, Fukuda H, Ishimura K, Ikeda H, Watanabe M, et al. Resolvin E1, but not resolvins E2 and E3, promotes fMLF-induced ROS generation in human neutrophils. FEBS Lett. 2018;592(16):2706\u201315. https:\/\/doi.org\/10.1002\/1873-3468.13215.","journal-title":"FEBS Lett"},{"issue":"10","key":"400_CR293","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1172\/jci96259","volume":"128","author":"M Schlegel","year":"2018","unstructured":"Schlegel M, K\u00f6rner A, Kaussen T, Knausberg U, Gerber C, Hansmann G, et al. Inhibition of neogenin fosters resolution of inflammation and tissue regeneration. J Clin Invest. 2018;128(10):4711\u201326. https:\/\/doi.org\/10.1172\/jci96259.","journal-title":"J Clin Invest"},{"issue":"3","key":"400_CR294","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/microbiolspec.MCHD-0001-2014","volume":"4","author":"J Dalli","year":"2016","unstructured":"Dalli J, Serhan C. Macrophage proresolving mediators-the when and where. Microbiol Spectr. 2016;4(3):10\u2013128. https:\/\/doi.org\/10.1128\/microbiolspec.MCHD-0001-2014.","journal-title":"Microbiol Spectr"},{"key":"400_CR295","doi-asserted-by":"publisher","unstructured":"Goicoechea M, Sanchez-Ni\u00f1o MD, Ortiz A, Garc\u00eda de Vinuesa S, Quiroga B, Bernis C, et al. Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients. Prostaglandins Leukot Essent Fatty Acids. 2017;125:8\u201313. https:\/\/doi.org\/10.1016\/j.plefa.2017.08.009.","DOI":"10.1016\/j.plefa.2017.08.009"},{"issue":"19","key":"400_CR296","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.21037\/atm-21-3986","volume":"9","author":"B Li","year":"2021","unstructured":"Li B, Yao BC, Guo ZG, Zhang SP, Song YQ, Jiang N, et al. Mechanism of action of resolvin D1 in inhibiting the progression of aortic dissection in mice. Ann Transl Med. 2021;9(19):1498. https:\/\/doi.org\/10.21037\/atm-21-3986.","journal-title":"Ann Transl Med"},{"issue":"8","key":"400_CR297","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacbts.2019.07.005","volume":"4","author":"RA Garc\u00eda","year":"2019","unstructured":"Garc\u00eda RA, Ito BR, Lupisella JA, Carson NA, Hsu MY, Fernando G, et al. Preservation of post-infarction cardiac structure and function via long-term oral formyl peptide receptor agonist treatment. JACC: Basic to Translational Science. 2019;4(8):905\u201320. https:\/\/doi.org\/10.1016\/j.jacbts.2019.07.005.","journal-title":"JACC: Basic to Translational Science"},{"key":"400_CR298","doi-asserted-by":"publisher","first-page":"14232","DOI":"10.1038\/ncomms14232","volume":"8","author":"CX Qin","year":"2017","unstructured":"Qin CX, May LT, Li R, Cao N, Rosli S, Deo M, et al. Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice. Nat Commun. 2017;8:14232. https:\/\/doi.org\/10.1038\/ncomms14232.","journal-title":"Nat Commun"},{"issue":"17","key":"400_CR299","doi-asserted-by":"publisher","first-page":"9003","DOI":"10.1021\/acs.jmedchem.9b02101","volume":"63","author":"Y Asahina","year":"2020","unstructured":"Asahina Y, Wurtz NR, Arakawa K, Carson N, Fujii K, Fukuchi K, et al. Discovery of BMS-986235\/LAR-1219: a potent formyl peptide receptor 2 (FPR2) selective agonist for the prevention of heart failure. J Med Chem. 2020;63(17):9003\u201319. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b02101.","journal-title":"J Med Chem"},{"issue":"3","key":"400_CR300","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/stem.2535","volume":"35","author":"SC Heo","year":"2017","unstructured":"Heo SC, Kwon YW, Jang IH, Jeong GO, Lee TW, Yoon JW, et al. Formyl peptide receptor 2 is involved in cardiac repair after myocardial infarction through mobilization of circulating angiogenic cells. Stem Cells. 2017;35(3):654\u201365. https:\/\/doi.org\/10.1002\/stem.2535.","journal-title":"Stem Cells"},{"issue":"8","key":"400_CR301","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/ph14080799","volume":"14","author":"M Kota\u0144ska","year":"2021","unstructured":"Kota\u0144ska M, Kubacka M, Bednarski M, Nicosia N, Szafarz M, Jawie\u0144 W, et al. The GPR18 agonist PSB-KD-107 exerts endothelium-dependent vasorelaxant effects. Pharmaceuticals (Basel). 2021;14(8):799. https:\/\/doi.org\/10.3390\/ph14080799.","journal-title":"Pharmaceuticals (Basel)"},{"key":"400_CR302","doi-asserted-by":"publisher","first-page":"102554","DOI":"10.1016\/j.redox.2022.102554","volume":"58","author":"J Zhang","year":"2022","unstructured":"Zhang J, Liu L, Zhang Y, Yuan Y, Miao Z, Lu K, et al. ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation. Redox Biol. 2022;58:102554. https:\/\/doi.org\/10.1016\/j.redox.2022.102554.","journal-title":"Redox Biol"},{"issue":"3","key":"400_CR303","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1161\/hq0302.105593","volume":"22","author":"RJ Aiello","year":"2002","unstructured":"Aiello RJ, Bourassa PA, Lindsey S, Weng W, Freeman A, Showell HJ. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol. 2002;22(3):443\u20139. https:\/\/doi.org\/10.1161\/hq0302.105593.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"400_CR304","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.7150\/thno.111503","volume":"15","author":"F Peng","year":"2025","unstructured":"Peng F, Qiu Z, Wang Z, Li F, Zhou F, Yuan S, et al. Harnessing mRNA for heart health: a new era in cardiovascular treatment. Theranostics. 2025;15(15):7779\u2013801. https:\/\/doi.org\/10.7150\/thno.111503.","journal-title":"Theranostics"},{"key":"400_CR305","doi-asserted-by":"publisher","first-page":"123199","DOI":"10.1016\/j.lfs.2024.123199","volume":"358","author":"F Peng","year":"2024","unstructured":"Peng F, Wang Z, Qiu Z, Zhang W, Zhao Y, Li C, et al. Nanomedicine in cardiology: Precision drug delivery for enhanced patient outcomes. Life Sci. 2024;358:123199. https:\/\/doi.org\/10.1016\/j.lfs.2024.123199.","journal-title":"Life Sci"},{"issue":"1","key":"400_CR306","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s42003-020-01410-5","volume":"3","author":"J Gao","year":"2020","unstructured":"Gao J, Wang S, Dong X, Leanse LG, Dai T, Wang Z. Co-delivery of resolvin D1 and antibiotics with nanovesicles to lungs resolves inflammation and clears bacteria in mice. Commun Biol. 2020;3(1):680. https:\/\/doi.org\/10.1038\/s42003-020-01410-5.","journal-title":"Commun Biol"},{"issue":"18","key":"400_CR307","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1016\/j.biomaterials.2014.03.001","volume":"35","author":"Y Jiang","year":"2014","unstructured":"Jiang Y, Chen J, Deng C, Suuronen EJ, Zhong Z. Click hydrogels, microgels and nanogels: emerging platforms for drug delivery and tissue engineering. Biomaterials. 2014;35(18):4969\u201385. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.03.001.","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"400_CR308","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijpharm.2015.12.037","volume":"498","author":"K Cholkar","year":"2016","unstructured":"Cholkar K, Gilger BC, Mitra AK. Topical delivery of aqueous micellar resolvin E1 analog (RX-10045). Int J Pharm. 2016;498(1\u20132):326\u201334. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.12.037.","journal-title":"Int J Pharm"},{"key":"400_CR309","doi-asserted-by":"publisher","first-page":"120475","DOI":"10.1016\/j.biomaterials.2020.120475","volume":"268","author":"MCP Sok","year":"2021","unstructured":"Sok MCP, Baker N, McClain C, Lim HS, Turner T, Hymel L, et al. Dual delivery of IL-10 and AT-RvD1 from PEG hydrogels polarize immune cells towards pro-regenerative phenotypes. Biomaterials. 2021;268:120475. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120475.","journal-title":"Biomaterials"},{"issue":"11","key":"400_CR310","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/term.3345","volume":"16","author":"X Jiang","year":"2022","unstructured":"Jiang X, Liu J, Li S, Qiu Y, Wang X, He X, et al. The effect of resolvin D1 on bone regeneration in a rat calvarial defect model. J Tissue Eng Regen Med. 2022;16(11):987\u201397. https:\/\/doi.org\/10.1002\/term.3345.","journal-title":"J Tissue Eng Regen Med"},{"key":"400_CR311","doi-asserted-by":"publisher","first-page":"100392","DOI":"10.1016\/j.mtbio.2022.100392","volume":"16","author":"B Lu","year":"2022","unstructured":"Lu B, Han X, Zou D, Luo X, Liu L, Wang J, et al. Catechol-chitosan\/polyacrylamide hydrogel wound dressing for regulating local inflammation. Mater Today Bio. 2022;16:100392. https:\/\/doi.org\/10.1016\/j.mtbio.2022.100392.","journal-title":"Mater Today Bio"},{"issue":"6s","key":"400_CR312","doi-asserted-by":"publisher","first-page":"188S","DOI":"10.1016\/j.jvs.2018.05.206","volume":"68","author":"B Wu","year":"2018","unstructured":"Wu B, Werlin EC, Chen M, Mottola G, Chatterjee A, Lance KD, et al. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model. J Vasc Surg. 2018;68(6s):188S-200S.e4. https:\/\/doi.org\/10.1016\/j.jvs.2018.05.206.","journal-title":"J Vasc Surg"},{"issue":"4","key":"400_CR313","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.4244\/eij-d-17-01081","volume":"15","author":"CCS Tseng","year":"2019","unstructured":"Tseng CCS, Wenker S, Bakker MH, Kraaijeveld AO, Dankers PYW, Seevinck PR, et al. Active tracked intramyocardial catheter injections for regenerative therapy with real-time MR guidance: feasibility in the porcine heart. EuroIntervention. 2019;15(4):e336\u20139. https:\/\/doi.org\/10.4244\/eij-d-17-01081.","journal-title":"EuroIntervention"},{"issue":"11","key":"400_CR314","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1074\/jbc.272.11.6972","volume":"272","author":"JF Maddox","year":"1997","unstructured":"Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, Serhan CN. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J Biol Chem. 1997;272(11):6972\u20138. https:\/\/doi.org\/10.1074\/jbc.272.11.6972.","journal-title":"J Biol Chem"},{"issue":"6","key":"400_CR315","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1159\/000527064","volume":"31","author":"O Karayi\u011fit","year":"2022","unstructured":"Karayi\u011fit O, Nurko\u00e7 SG, Ba\u015fyi\u011fit F, K\u0131z\u0131ltun\u00e7 E. The role of serum Resolvin D1 levels in determining the presence and prognosis of ST-segment elevation myocardial infarction. Med Princ Pract. 2022;31(6):548\u201354. https:\/\/doi.org\/10.1159\/000527064.","journal-title":"Med Princ Pract"},{"issue":"1","key":"400_CR316","doi-asserted-by":"publisher","first-page":"9853","DOI":"10.1038\/s41467-025-64827-8","volume":"16","author":"J Park","year":"2025","unstructured":"Park J, Oh D, Yoo J, Ha H, Kim D, Kim HH, et al. Clinical ultrasound, photoacoustic, and fluorescence image-guided lymphovenous anastomosis microsurgery via a transparent ultrasound transducer array. Nat Commun. 2025;16(1):9853. https:\/\/doi.org\/10.1038\/s41467-025-64827-8.","journal-title":"Nat Commun"},{"key":"400_CR317","doi-asserted-by":"publisher","unstructured":"Raju TN. The Nobel chronicles. 1950: Edward Calvin Kendall (1886\u20131972); Philip Showalter Hench (1896\u20131965); and Tadeus Reichstein (1897\u20131996). Lancet. 1999;353(9161):1370. https:\/\/doi.org\/10.1016\/s0140-6736(05)74374-9.","DOI":"10.1016\/s0140-6736(05)74374-9"},{"issue":"7","key":"400_CR318","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/ard.2008.092163","volume":"68","author":"D Huscher","year":"2009","unstructured":"Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis. 2009;68(7):1119\u201324. https:\/\/doi.org\/10.1136\/ard.2008.092163.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"400_CR319","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jaad.2016.02.1239","volume":"76","author":"A Caplan","year":"2017","unstructured":"Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects. J Am Acad Dermatol. 2017;76(1):11\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1239.","journal-title":"J Am Acad Dermatol"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00400-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T03:54:23Z","timestamp":1767585263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00400-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":319,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00400-5","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}